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“Life is not easy for any of us.  
But what of that?  
We must have perseverance and  
above all confidence in ourselves.  
We must believe that we are gifted for  
          something and that this thing must be attained.” 
Marie Curie  
 RESUMO 
Este trabalho visou o uso de um sistema microfluídico de gotas para incorporar ácidos 
nucleicos em lipossomas catiônicos e outro para estudar o processo de transfecção em 
células de mamíferos. A primeira etapa do projeto utilizou um microdispositivo para 
incorporar pDNA em lipossomas catiônicos de modo a obter lipoplexos reprodutíveis e 
adequados para transfectar células dendríticas (DCs). Com esta finalidade, alguns 
parâmetros experimentais foram investigados, tais como vazões de entrada, 
manutenção das propriedades dos lipossomas após processamento no 
microdispositivo, características dos lipoplexos (tamanho, polidispersidade e carga) em 
função da razão molar de carga (R+/-) e do desenho do microdispositivo. Lipoplexos 
produzidos em microdispositivo com canal de serpentina largo e região de divisão de 
gotas que diminuem a polidispersidade dos lipoplexos, operando à razão de vazão 
água/óleo 0,25 e R+/- 1,5; 3; 5; 7 e 10 foram utilizados para transfectar DCs in vitro. 
Todos os lipoplexos foram capazes de transfectar as DCs e ao mesmo tempo 
proporciaonar a ativação das células. A segunda etapa do trabalho utilizou uma 
plataforma microfluídica de célula única para investigar e controlar as condições de 
transfecção, tendo em vista a otimização dos rendimentos de produção de proteínas 
recombinantes. Neste contexto, as células de ovário de hamster Chinês (CHO-S) foram 
transfectadas no microdispositivo com diferentes tipos de lipoplexos (R+/- 1,5; 3; 5) e 
monitoradas em relação à produção de proteína verde fluorescente (GFP) e viabilidade 
celular. A plataforma de célula única permite avaliar a heterogeneidade celular, 
revelando a presença de uma subpopulação que produz níveis elevados de GFP. Essas 
células com alta produção de GFP (HP) mostraram um aumento do tamanho celular em 
comparação à média da população. Além disso, a carga dos lipoplexes apresenta um 
importante papel na transfecção das células CHO-S, visto que os únicos lipoplexos com 
carga positiva R+/- 5 produziram mais HPs. A quantidade de pDNA entregue às células 
afeta a produção de proteína, já que os lipoplexos com mais pDNA R+/- 1,5 aumentaram 
a produtividade específica de GFP das HPs. Esta tese foi desenvolvida no âmbito de 
um programa de co-tutela entre a Universidade Estadual de Campinas, Brasil e a École 
Polytechnique, França. Em geral, este trabalho apresenta contribuições originais para 
as áreas da microfluídica e da entrega de genes. 
Palavras-chave: sistema microfluídico de gotas, liposomas catiônicos, transfecção, 
pDNA, entrega de genes, células dendríticas, células CHO.  
 ABSTRACT 
This work aimed at using one droplet-based microfluidic systems to incorporate nucleic 
acids into cationic liposomes and another one to study the mammalian cell transfection 
process. In the first part of this study we used a droplet-based microfluidic system to 
complex cationic liposomes with pDNA in order to obtain reproducible and suitable 
lipoplexes to dendritic cells (DCs) transfection. For this purpose, some experimental 
parameters were investigated, such as inlet flow rates, the maintenance of liposomes’ 
properties after microfluidic processing, lipoplex characteristics (size, polydispersity and 
zeta potential) as function of molar charge ratio (R+/-) and microchip design. Lipoplexes 
produced in a microchip with large serpentine channel and split region, which decreases 
lipoplex polydispersity, operating at ratio aqueous/oil flow rate 0.25 and R+/- 1.5, 3, 5, 7 
and 10 were used to transfect DCs in vitro. All lipoplexes transfected DCs and resulted 
in cell activation. In the second part of this study we used a single-cell microfluidic 
platform to investigate and control transfection conditions, in view of optimizing the 
recombinant protein production by transfected cells. Chinese hamster ovary cells (CHO-
S) were transfected in microchip with different types of lipoplexes (R+/- 1.5, 3, 5) and 
monitored by green fluorescent protein (GFP) production and cell viability. The single-
cell platform enables to assess the heterogeneities of CHO-S population, revealing the 
presence of a subpopulation producing significantly high levels of GFP. These high 
producers (HP) showed increased cell size in comparison to the average population. 
Moreover, the charge of lipoplexes shows an important role to transfect CHO-S, since 
the unique positive charged lipoplex R+/- 5 produced more HPs. Additionally, the amount 
of pDNA delivered affects protein production, since R+/- 1.5 with more pDNA increased 
GFP specific productivity of HPs. This thesis was developed under the joint graduate 
program of the University of Campinas, Brazil and École Polytechnique, France. In 
general, this work presents original contributions in the areas of microfluidics and gene 
delivery.  
Keywords: droplet-based microfluidic system, cationic liposomes, transfection, pDNA, 
gene delivery, dendritic cells, CHO cells.   
 
 RÉSUMÉ 
Ce travail consiste à utiliser deux systèmes microfluidiques de gouttes pour incorporer 
d'une part des acides nucléiques dans des liposomes cationiques et d'autre part étudier 
la dynamique de transfection dans des cellules mammifères. La première micropuce 
permet d'insérer de l'ADN dans des liposomes cationiques afin d'obtenir de manière 
reproductible des lipoplexes appropriés à la transfection de cellules dendritiques (DC). 
Plusieurs paramètres expérimentaux sont tout d'abord étudiés, tels que les débits 
d'entrée, l’entretien des propriétés des liposomes après leur traitement dans des micro-
gouttes, les caractéristiques des lipoplexes (taille, polydispersité et charge) en fonction 
du rapport molaire de charge (R+/-) et de la géométrie de la puce. Ensuite, les lipoplexes 
produits dans une micropuce avec un grand canal en serpentin et une région de division 
des gouttes qui diminuent la polydispersité des lipoplexes, fonctionnant à un rapport de 
débit eau/huile 0,25 et R+/- 1,5; 3; 5; 7 et 10; sont utilisés pour transfecter des DCs in 
vitro. Tous les lipoplexes transfectent les DCs, tout en offrant une activation des DCs. La 
seconde étape consiste à utiliser une micropuce à l'échelle de la cellule unique afin de 
contrôler les conditions de transfection et d'optimiser le rendement de production de 
protéines recombinantes. Ainsi, des cellules ovariennes de hamster Chinois (CHO-S) 
sont transfectées dans la micropuce avec différents types de lipoplexes (R+/- 1,5; 3; 5) 
dont la dynamique de transfection est suivie par la production de protéines vertes 
fluorescentes (GFP) et par la viabilité cellulaire. Cette micropuce a permis d'évaluer 
l’hétérogénéité des cellules transfectées, révélant la présence d'une sous-population 
produisant des niveaux particulièrement élevés de GFP. Ces hautes productrices (HP) 
ont une taille cellulaire plus importante que celle de la population moyenne. La charge 
des lipoplexes montre un rôle important pour transfecter CHO-S, puisque l’unique 
lipoplex chargé positif R+/- 5 produit plus de HPs. La quantité d’ADN délivrée influe sur la 
production de protéine, puisque R+/- 1,5 avec plus d’ADN augmente la productivité 
spécifique de GFP des HPs. Cette thèse est réalisée dans le cadre d'un programme de 
co-tutelle entre l'Université de Campinas, au Brésil, et l'École Polytechnique, en France. 
Ce travail a principalement présenté des contributions originales aux domaines de 
microfluidique et de délivrance de gènes. 
Mot-clés: microfluidique des gouttes, liposomes cationiques, transfection, ADN, 
délivrance de gènes, cellules dendritiques, cellules CHO. 
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Chapter I - Introduction 
_______________________________________________________________________________ 
1. Introduction   
Gene therapy refers to the transmission of nucleic acid encoding a gene of 
interest into the targeted cells or organs with consequent expression of the 
transgene (1). A key factor in the success of gene therapy is the development of 
delivery systems capable of efficient gene transfer (2). Nanovectors are usually 
classified as viral and non-viral, and within the current range of non-viral vectors, 
cationic liposomes are particularly promising (1,3). Cationic liposomes are mainly 
composed of cationic lipids to ensure their positive superficial charge, which leads 
them to interact electrostatically with negatively charged nucleic acids sequences 
to form complexes capable of entering a cell (3). Cationic liposomes are superior to 
viral vectors in terms of reproducibility, safety of use, in addition to being 
biocompatible and biodegradable; however, they are inferior to viral vectors in 
terms of transfection efficiency (4).  
Recent advances in microfluidics have created new and exciting prospects for 
gene delivery and therapy. The micro-scaled environment within microfluidic 
systems enables precise control and optimization of multiple processes and 
techniques used in gene transfection and the production of gene and drug 
transporters (5). In particular, water-in-oil microdroplets provide an alternative 
experimental format as the droplet defines a reaction compartment, leading to a 
reduction of many orders of magnitude in the reaction volumes required. It has also 
been shown that droplets generated by microfluidic devices are extremely uniform, 
which is seemingly adequate for encapsulation of single cells and synthesis of 
gene delivery systems (6,7).  
Droplet-based microfluidic systems structured as mixer devices provide a 
rapid mixing of reacttants (8). Microsystems working only with parallel streams 
have the fluid mixing mainly promoted by diffusion, whereas droplet-based 
microsystems can add a chaotic advection contribution that increases the mixing in 
the system (9). Micromixers have important applications such as control chemical 
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reactions (10), promote protein crystallization (11), improve biochemical analysis 
(12) and complex nanoparticles and nucleic acids (lipoplexes) (7).  
Conventional methods of obtaining lipoplexes involve just the mixing provided 
by hand shaking or vortexing to reach cationic liposomes complexation with nucleic 
acids. However, these conventional methods introduce variability in lipoplexes 
formation and, as a result, provide inconsistent transfection efficiencies (7). Some 
hard-to-transfect cells, like dendritic cells (DCs) (13), depends on transfection 
pathways that are extremely dependent of lipoplexes size and polydispersity (14). 
The importance to loaded DCs with tumor antigens for immunotherapeutic 
approaches has been pointed by others (15). Thus, the study of methodologies to 
form lipoplexes specific for different cells lines in a reproducible and controllable 
way is very important (16). Hsieh et al. (7) developed a picolitre incubator based 
microfluidic system to complex commercial liposomes with pDNA, showing the 
robusteness of the microsystem to produce reproducible lipoplexes and also to 
transfect cells, emerging as an alternative to conventional methods (7).  
Moreover, droplet-based microfluidic systems can be used for analyzing 
single cells, since droplets provide the rapid detection of molecules secreted by 
cells due to the low volume surrounding each encapsulated cell. The risk of cross-
contamination decreases and cells can be studied individually by fluorescence 
techniques (17). Droplet microchips linked to fluorescent equipment let adherent 
and non-adherent mammalian cells analysis, manipulation/investigation of the 
content from disrupted single cells (18). In addition, single-cells in droplets can be 
monitored over time instead of only few check points, which highlights the 
response of individual cells in short-times even if cell population signal appears 
relatively homogeneous during experience (19). However, to maintain cell viability 
inside droplets is a challenge, since there are risks of coalescence, nutrient 
depletion or the accumulation of toxic metabolites. Thus, these points should be 
considered before robust analysis over longer periods of time (17). Despite these 
drawbacks, one research group has shown that cell cultivation in single-cell 
platforms is possible (20).  
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The application of microfluidics platform to dynamically track individualized 
cell responses open up the possibility to better understand cell heterogeneity after 
transient gene expression (21). Biotechnology industry widely uses CHO cells to 
produce recombinant proteins by transient transfection, which is usually more 
suitable for fast and large protein production in the first steps of drug development 
(22). Consequently, in view of optimizing the production yields, a better 
understanding and control over the transfection conditions at single cell level using 
transition gene expression are critically required. 
In this context, the application of droplet-based microfluidic technology to 
synthesize lipoplexes and to transiently transfect mammalian cells in vitro can 
contribute to gene delivery advancements. For this purpose, in the first part of this 
work, we investigated some parameters that influence lipoplexes synthesis in 
droplet-based platform. The aim was to form lipoplexes in microfluidic conditions 
that provide them physico-chemical properties suitable to transfect DCs in vitro. 
Additionally, in single-cell analyze field, we transfected CHO-S cells in a universal 
microfluidic platform for bioassays. The transient transfection was performed by 
different types of lipoplexes (molar charge ratios between cationic lipids and 
nucleic acids), leading to conclude about the influence of lipoplexes in the 
heterogeneities of cell population. This thesis was developed under a co-
supervision program between University of Campinas - Brazil and École 
Polytechnique – France, and possible due to the collaboration headed by 
Professor Lucimara de la Torre specialized in gene delivery systems in Brazil and 
the one headed by Professor Charles Baroud with expertise in lab-on-a-chip 
devices for biological applications in France. 
2. Objectives 
The general-purpose of the project was to contribute in nanobiotechnology, 
microfluidics and gene delivery areas. In particularly, this work aimed to apply 
droplet-based microfluidic systems to produce lipoplexes with characteristics to 
transfect DCs and to investigate CHO-S cell transfection process by single-cell 
analysis during culture time. Thus, the first goal was to ensure the maintenance of 
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liposomes’ properties after droplet system processing and the lipoplex formation 
with the required characteristics to transfect DCs. Then, we investigated more 
deeply the influence of different types of lipoplexes in mammalian cell transfection. 
For this, a universal microfluidic platform was used to transient transfect CHO-S 
cells by different types of lipoplexes. With the single-cell analysis provided by the 
platform, we intended to associate the type of lipoplex with the heterogeneities in 
GFP production by CHO-S population.  
To achieve these aims, the research followed these goals:  
 Lipoplexes synthesis in droplet-based microfluidic device to transfect DCs:  
Investigate how experimental microfluidic parameters influence on lipoplex 
properties in order to obtain reproducible and suitable lipoplexes to DCs 
transfection. 
 CHO-S transfection in a single-cell microfluidic platform:   
Evaluate how different types of lipoplexes influence on transient transfection of 
CHO-S cells by single-cells analysis.   
3. Thesis organization 
The thesis is organized in chapters, as described below. The results were 
presented as original research papers (Chapter III and IV) that will be submitted to 
international journals, according to the content addressed. Therefore, the sections 
introduction, materials and methods, results and discussion and conclusion of each 
part of the thesis are included in the research paper of their respective chapter.     
 Chapter I – Introduction  
 Chapter II – Literature review  
This chapter shows an overview of gene therapy, cationic liposomes, 
microfluidics, droplet-based systems and their application in lipoplexes synthesis 
and to transfect mammalian cells in vitro in a single-cell approach. The text was 
adapted from a Book Chapter (“Trends on microfluidic liposome production through 
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hydrodynamic flow-focusing and microdroplet techniques for gene delivery 
applications”) and a Review Article (“Droplet-based microfluidic systems for 
production and transfection in vitro of non-viral vectors for gene delivery”) 
published during the thesis, having Micaela Tamara Vitor as co-author. 
 Chapter III – Droplet Microfluidic-Assisted Synthesis of Lipoplexes for DC 
Transfection 
This chapter shows the application of a droplet-based microfluidic system to 
investigate the complexation of EPC/DOTAP/DOPE liposomes with pDNA to obtain 
reproducible and suitable lipoplexes to DCs transfection. For this purpose, some 
experimental parameters were investigated, such as inlet flow rates and cationic 
liposomes physico-chemical properties after droplet processing. With the system 
operating with ratio aqueous/oil flow rate 0.25, droplets were formed with size 1.5 
times of the serpentine channel. Cationic liposomes maintain their properties after 
the processing, even with surfactant residual in the aqueous phase. Then, lipoplex 
characteristics were investigated as function of molar charge ratio (R+/-) and 
microchip design. An optimal condition of lipoplexes synthesis was obtained using 
the droplet-based microfluidic system with wide serpentine channel and split 
region, operating at ratio aqueous/oil flow rate 0.25 and in all R+/- tested (1.5, 3, 5, 
7 and 10). Then, these lipoplexes were evaluated in their capacity to transfect DCs 
in vitro while activating cells. The best transfection efficiency was achieved with 
lipoplexes R+/- 10 and they also activated DCs, important effect for immunological 
applications.  
 Chapter IV – Tracking the Heterogeneities of CHO Cells Transiently 
Transfected on a Chip 
This chapter shows the use of a universal droplet-based platform to transfect 
CHO-S cells using different types of lipoplexes (R+/- 1.5, 3, 5). Aiming to optimize 
the production yields in transient transfection, the heterogeneities of CHO-S 
population were explored through single-cell analysis provided by the platform. The 
GFP production kinetics revealed the presence of a subpopulation producing 
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significantly high levels of recombinant proteins. These high producers (HPs) 
showed increased cell size in comparison to the average population, suggesting 
that they are mainly distributed into cell-division cycle. Lipoplexes with positive 
charge and less pDNA (R+/- 5) produced more HPs and lipoplexes with negative 
charge and more pDNA (R+/- 1.5) increased GFP specific productivity of HPs. 
 Chapter V – Conclusions 
 Chapter VI – Future perspectives 
ANNEX I – Plasmid vectors 
ANNEX II – Preliminary studies in droplet microfluidic system to synthesize 
lipoplexes 
Investigation of flow rates to droplets formation in a water/oil emulsion using 
less expensive reagents and study of CL formation in different diluents in order to 
obtain nanoparticles with required physico-chemical characteristics to DC 
transfection. 
ANNEX III – Preliminary studies in droplet microfluidic system to transfect CHO-S 
cells 
Before reach the system presented in Chapter III to transfect CHO-S cells, 
others cells and microdevice were explored and leaved, because of low viability or 
transfection of cells. Even though, the device showed a potential to understand key 
parameters that influence in vitro mammalian cells transfection process and so 
were presented in this annex.  
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1. Introduction   
Gene delivery is a promising technique that involves the insertion of nucleic 
acid inside target cells for curing a disease or at least improving the clinical status 
of a patient (1). One important step of gene therapy is the transfection process that 
introduces foreign nucleic acids into cells to produce genetically modified cells (2). 
In this context, the development of delivery systems capable of efficient and safe 
gene transfer (3), while protecting the genetic material from different barriers 
(extracellular matrix, cell membrane, cytosol, nuclear membrane) (4), is necessary.  
Among the delivery systems, cationic liposomes stand out due to their 
reproducibility, safety of use, biocompatibility and biodegradability (5). However, 
besides the promising results of cationic liposomes, the development of methods to 
insert nucleic acids into cationic liposomes in a control and reproducible way is still 
a challenge. Depending on cell lines, the production of lipoplexes with specific 
physico-chemical properties is required for transfection (6).  
On the other hand, microfluidics, technology that manipulates small amounts 
of reactants inside microchannels, appears as a powerful strategy to overcome 
these drawbacks (7). The microenvironment of microfluidic systems allows precise 
control and optimization of multiple processes and techniques used in gene 
therapy (8). Moreover, droplet-based microfluidic systems define microreactors that 
reduce of many orders the volume manipulated, being attractive for molecular 
biology assays (9). Droplets moving in some microfluidic systems with specific 
geometry become micromixers that provide a rapid mixing of reagents (10). 
Droplet-based microfluidic systems can be also used to transfect cells in vitro. 
Since microfluidics generates extremely uniform droplets, they are appropriate for 
single-cell encapsulation and/or for in vitro expression of single genes (11). 
Molecules secreted by cells are fast detected due to the low volume surrounding 
each cell, allowing investigation of transfection parameters in culture real time 
(9,12).  
In this literature review, first we present an overview about gene therapy and 
the role of non-viral vectors. Then, we show the state-of-the-art of current 
microengineering methods based in droplet microfluidic platforms for the 
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production of lipoplexes and mammalian cell transfection. The understanding of 
this technology and how fluid dynamics influences the microscale for the 
production of controllable and stable droplets give the insight to understand how to 
form complexes for gene delivery applications. At last, we show methods of 
transfection inside droplets comparing with the conventional transfection in wells.     
2. Nanoparticles as non-viral vectors for gene delivery  
Gene therapy refers to the transfer of genetic material encoding a therapeutic 
gene of interest into a cell, tissue, or whole organ with consequent expression of 
the transgene in order to treat a disease. However, for the success of gene 
therapy, the development of sophisticated and efficient delivery systems capable of 
transfering genes is a key factor (3,13). In brief, we can describe two classes of 
efficient nucleic acid carriers: viral and non-viral vectors. These delivery systems 
should protect nucleic acids from degradation, while providing a safe intracellular 
delivery (14). Over a decade ago, patients with immunodeficiency-X1 were treated 
with gene therapy assays based on the use of cDNA in a retrovirus (15,16). After 
that, gene therapy based on retrovirus vector was used to treat French patients 
with T cell leukemia, producing aberrant transcription and expression of LMO2 
(17). These facts opened an optimistic vision about gene therapy research. 
Nowadays, gene therapy clinical trials are present in worldwide, mainly in United 
States of America (62.6%), United Kingdom (10.3%) and Germany (4.1%). These 
therapies are usually used in the treatment of cancer (63.8%), monogenic diseases 
(8.9%) and infectious diseases (8.2%) (18). The most commonly vectors used in 
gene therapy are still virus vectors, highlighting adenovirus (22.5%) and retrovirus 
(18.8%), but also lipofection (5.2%) and naked pDNA (17.5%) are raising their use 
(18). Notwithstanding the high efficient transfection provided by viral vectors, they 
can invoke immune responses or proto-oncogene activations. In this context, the 
non-viral vectors, particularly cationic liposomes, have a promise and potential 
future, taking into account their reproducibility and safety of use (5).  
Cationic liposomes are non-viral vectors mainly composed of cationic lipids, 
which guarantee their positive superficial charge. Examples of synthetic cationic 
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lipids used in cationic liposome composition are DOTAP (1,2-dioleoyl-3-
trimethylammonium propane), DOTMA (2,3-bis(oleyl)oxypropyl-
trimethylammonium chloride), DDAB (dimethyl dioctadecyl ammonium bromide), 
DC-Chol (3 β [N-(N’,N’-dimethylaminoethane)-carbamoyl]cholesterol), DMRIE (N-
(2-hydroxyethyl)-N,N-dimethyl-2,3-bis(tetradecyloxy)-1-propanaminium bromide), 
DOGS (dioctadecyl amino glycyl spermine), DOSPA (2,3 dioleyloxy-N-[2(spermine 
carboxaminino)ethyl]-N,N-dimethyl-1-propanaminium trifluoroacetate). However, 
the use of cationic lipids can generate cell toxicity, and so the inclusion of others 
lipids, e.g. egg phosphatidylcholine (EPC), in cationic liposome composition is 
required to decrease the cytotoxicity (19,20). On the other hand, the positive 
charge of cationic liposomes provides an electrostatic interaction with negatively 
charged nucleic acids, forming complexes with net positive charge (21). Hence, 
these positive charged complexes can enter easily inside cells, whose surface 
membrane is negatively charged (22). Once into cells, the complexes should 
release the nucleic acids in cytosol, in case of RNA for rapid synthesis of a target 
protein (23), or in cell nucleus, in case of DNA to control gene expression for a 
more long-term. The inclusion of helper lipids, e.g. phosphatidylethanolamines 
(DOPE), in cationic liposomes composition facilitates the nucleic acid to escape 
inside the cytosol (24). Felgner et al. (22) were pioneers in the development of 
cationic liposomes for gene delivery. They produced liposomes composed of 1:1 
ratio of DOTMA and DOPE, which were then commercialized as Lipofectin. For 
example, these cationic liposomes were used in vitro to carrier efficiently hepatitis 
C virus proteins into a human hepatocyte cell line (HUH7) (25) and in vivo to 
delivery linamarase gene for the treatment of brain tumors in animals or humans 
(26). Recently, other commercial cationic liposomes, such as Lipofectamine, 
DMRIE-C, Oligofectamine, Ambion, 293fectin, Optifecta, Invivofectamine, 
FuGENE, TransFast, TransFection and CLONfectin, are being used in gene 
therapy due to their well-established protocols and to provide high efficiency of 
transfection in some specific cells and with some specific nucleic acids. Our 
research group (27) also showed the feasibility of dehydrated-rehydrated 
liposomes composed of EPC, DOTAP and DOPE (50/25/25% molar, respectively) 
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carrying polynucleotides encoding HSP65, for prevention and treatment of 
tuberculosis. And more recently, we obtained the same cationic liposomes 
produced in a large scale by ethanol injection method to delivery nucleic acid into 
dendritic cells (DCs) as a potential tool for cancer immunotherapy (28).  
Dendritic cells are professional antigen-presenting cells widely used in 
immunotherapeutic approaches, particularly in immunotherapies against cancer. 
Since loaded with tumor antigens, mature DCs can induce an immune response 
against cancer by recruiting patients’ immune system (29). Different strategies are 
currently used to load DCs with antigens, e.g. peptide pulsing, pulsing with tumor 
cell lysates, infection with viral vectors, direct nucleic acid loading, or 
ingestion/fusion with tumor cells (30). Moreover, cationic liposomes stand out in 
this function as gene carriers, since besides to transfect DCs, they can also 
activated them (31). Particularly, our research group (32,33) showed that cationic 
liposomes EPC/DOTAP/DOPE were uptake by DCs, while providing cells 
stimulation/activation. However, dendritic cells require that these cationic 
liposomes have a very specific properties (size < 100 nm and polydispersity <0.2) 
to be internalized (32), due to the use of macropinocytosis and/or phagocytosis as 
transfection pathways (34). Thus, the study of methodologies that enable to form 
lipoplexes modulated to specific cells lines in a reproducible and controllable way is 
very important (35). Conventional methods of obtaining lipoplexes involve just the 
mixing provided by hand shaking or vortexing to reach cationic liposomes 
complexation with nucleic acids. However, these conventional methods introduce 
variability in lipoplexes formation and, as a result, provide inconsistent transfection 
efficiencies (6). To effectively transfect cells, the physico-chemical properties of 
lipoplexes should be suitable to the pathway used by the cell line to internalize 
nanoparticles (36).  
3. Microfluidic droplet technologies  
The general concept of microfluidics is in the manipulation of small amounts 
of reactants inside microchannels with the capability to control and manipulate 
molecules in space and time (37). In microfluidics it is possible to work with small 
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amounts of  reactants, the period of reactions is short, it is possible to work with 
parallel operations (38), large surface to volume ratio allows fast diffusion of 
compounds and fast mass/heat transfer (39). These advantages can be related to 
the flow in microfluidic devices, which is laminar and corresponds to a low 
Reynolds number (37,40). Another important consequence of this regime is that 
the mixture between two parallel flowing streams occurs mainly by diffusion (38).  
The origin in microfluidic is in the 90´s for MicroElectroMechanical Systems 
area (MEMS) (39). Nowadays microfluidics has been exploited in numerous areas 
as: 
 Biological analyses - detection of biomolecules (41,42), manipulation and 
amplification (43) and separation of DNA by capillary electrophoresis (44). 
Microbial growth - Screening of variables and kinetic parameters (45,46). 
Nanoparticles production – polymeric particles (47,48), liposomes and lipid 
vesicles (49–51), metallic nanoparticles (52). 
Gene Delivery/Transfection – electroporation (53), hydrodynamic force and 
optical energy (8). 
Different materials can be used for the construction of microchannels and, for 
biological application, glass and polymers are detached (54). Glass is considered 
to be biocompatible, impermeable to gases (54,55), has physic and chemical 
stability and it is hydrophilic (54).  The techniques to prepare microdevices in glass 
are laser ablation and wet etching (54). Microdevices can also be made by 
polymers which are not expensive, there is the possibility to change the chemical 
formulation (55), are stable (37) and hydrophobic (54). The elastomer which has 
been used extensively for microdevices construction is poly(dimethyl syloxane) 
well-known as PDMS , moreover the technique employed is soft lithography (56).  
In addition, it is important to consider the wettability related to the 
microchannel material and the droplet system. Since the continuous phase wets 
the walls faster than the disperse phase and forms a thin film between droplet and 
walls (57). The droplet breakup occurs when the continuous phase wets the device 
walls instead the disperse phase, thus the droplet morphology is a result of the 
interaction between the material which the devices is formed and the continuous 
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phase (57). Summarizing hydrophobic channels are required to prepare water in oil 
systems,  inversely hydrophilic channels are necessary for forming oil in in water 
emulsions (58). Considering the advantages of using PDMS for devices 
construction, in the literature different strategies are reported to change the 
wettability of the material, through chemical modifications (58,59).  
Microfluidic systems can be classified according to the interfaces created by 
the fluid flows in microchannel as: pinned interfaces, in which fluids flow in parallel 
creating vertical interfaces, and floating interfaces, in which immiscible fluids 
produce droplets of precise shape (60). The use of segmented flow which the 
reactants are separated in different picoliter/nanoliter droplets has been used in 
cases when miniaturized systems has to be achieved (61).  The segmented flow is 
the principle of emulsions which are a metastable colloidal systems (62) with two 
immiscible liquids. In this case there is one continuous phase and one disperse 
phase in droplets formats (57,61). Some advantages of droplet processes can be 
described in comparison with parallel flows processes. In parallel flows, in which 
solute are all distributed over the solvent,  the efficiency of chemical reactions and 
the detection of some molecules inside the channels can be decreased, this 
phenomenon is called Taylor-Aris dispersion (63,64). The use of droplets 
processes cut out the contact with solid wall,  reducing the probability of reagents 
adsorption into the channels walls (64). Droplets with samples inside can be seen 
as micro-reactors which allows the manipulation of small volumes (14,65). In 
addition,  in droplets microfluidics it is possible to carry out many reactions without 
increasing the number and the channels size (13). Furthermore, considering the 
relation between the surface area and volume, the reactions inside droplets are 
faster because the heat and mass transfer times and also diffusion distances are 
shorter (13,66).  
In order to form stable droplets, the use of appropriated surfactants is 
important. Surfactants are known as amphiphilic molecules with different groups 
and having affinity for different phases which are immiscible. Due to different 
groups in the structure, surfactant molecules go to interface and as a result the 
surface tension between the phases decreases (67). An essential requirement to 
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use droplets as microreactors is to avoid the coalescence of them. Thus the 
surfactant addition provides stabilization in the metastable state (62,67). 
Furthermore choose biocompatible surfactants is the rule for the success of droplet 
system application in biological fields (67). Fluorinated oils are promising to be 
used in biotechnology area; however few surfactants are available to stabilize 
water in oil interfaces emulsions (67). Different molecules are being studied and 
developed to microfluidic applications. Nowadays, block copolymer of 
perfluoropolyether and polyethylenoxide are the most interesting molecules 
existent. It is known that these molecules reduce protein adsorption or the 
interactions with cell membranes (67). Another important molecule is a triblock 
copolymer surfactant composed of perfluoropolyether (PFPE) and polyethylene 
glycol (PEG) blocks (68). However the problem is the limitation of surfactant 
modification which can be just by varying the molecular weight or chain-end 
functionalization. In this way, Wagner et al (68) proposed to synthetize  and 
characterize polyglycerol-based triblock surfactants, and exemplified in droplet-
based microfluidics their application in cell encapsulation and in vitro gene 
expression studies.  
The droplet compartments formed in microfluidic systems have many 
functions. The uniformity and the little volume of these droplets allow them to be 
used for quantitative assays requiring reduced volumes of reagents, and as a 
result, providing a low cost for this technique (69). Moreover, droplets compartment 
design can furnish combined information about molecules function (activity or 
inhibitory functions), molecules identity and molecules ability to carry out its 
function by measuring, for example, a fluorescence product. In addition, droplets 
give the possibility to make several unit operations in a device, like droplets can be 
divided, fused, incubated, analyzed, sorted and broken up (70). Moreover, the 
compartments formed by droplets can be used as micromixers, providing efficient 
and controlled mixing over the reactants inside microcontainers (66).  
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4. Droplet-based microfluidic platforms for lipoplexes formation  
The control and rapid mixing of reagents within droplet-based microfluidic 
systems (micromixers) can be used, for example, to make an effective 
complexation between nucleic acids and liposomes in order to form lipoplexes (35). 
Microsystems using parallel flows, the mixing is promoted mainly by the diffusion of 
reactants (31). In contrast to this, microdroplets devices can add a chaotic 
advection contribution to the system, increasing the promoted mixing. For example, 
serpentine channels can generate two recirculation flows within droplets due to the 
shear created between the droplets and channel wall (31) (Figure 2.1). For this, 
droplets should have a precise size to touch the inner surface channels and 
generate a fluid movement relative to the stationary walls of serpentine channel 
(10). On the whole, micromixers can be classified as passive and active. The 
passive micromixers require the use of different microchannel geometries and/or 
liquid flow rates to generate mixing (54). On the other hand, active micromixers 
demand an external energy to enhance the mixing, such as pneumatic or 
mechanical vibration (71). Active mixers require more complex fabrication 
processes and they are more difficult to integrate with other microfluidic 
components. The passive mixers usually adopt longer mixing channels without 
external agitation (72).  
Nevertheless, some parameters of the system have to be taken into account 
to provide an effective mixing within droplets. One of the most important parameter 
is capillary number (Ca), which should be low in order to form droplets in the 
system (73). The Ca is proportional to the average flow velocity (U) and inversely 
proportional to the interfacial velocity (γ/μC, where γ is the surface tension between 
two immiscible phases and μC is the dynamic viscosity of continuous phase). 
Hence, when the flow velocity is much lower, Ca is reduced and the surface 
tension controls the system. In high Ca, the shear force dominates (73). As 
consequence, the viscosity of fluids is another parameter that interferes in 
interfacial velocity and in droplets mixing (74). Tice et al. (74) concluded that 
combination of viscous and non-viscous fluids promotes a more efficiently mixing 
inside droplets than the use of only non-viscous fluids. Thus, the use of fluids with 
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approximated viscosities decreases the interfacial velocity of the system, inducing 
a decrease in droplets mixing (74). Moreover, the channel configuration is also 
fundamental in a good mixing within droplets. The channel width is often used to 
control the local flow velocity, when the channel depth and flow rate being kept 
constant (75). Furthermore, microsystems should be operate in a Peclet number 
between 1000 times and 100,000 times greater than Reynolds for a good mixing 
(76). According to the Peclet number, it is possible to determine if the convection 
mixing (UL, where L is a characteristic length scale) or the diffusion mixing (D, 
where D is a characteristic diffusion coefficient) dominates in the system (77).  
Besides setting operational parameters in the droplet microfluidic system, to 
achieve a chaotic mixing in passive micromixers, especial geometries, such as 
serpentine channels outlined in Figure 2.1, can be adopted (77). Chaotic advection 
provides an accelerated mixing within droplet-based microfluidic devices, 
stretching and folding the fluid into droplets as long as they pass in these channels 
(40). Droplets moving downstream and upstream in serpentine channels offer an 
alternating motion time periodically influenced by the walls, creating fluid vortexes 
(40). In brief, the mechanism can be explained as follows: the part of droplet in 
contact with the outside arc of the channel prompts greater contact between the 
interface of the droplet and the channel wall, leading to a longer recirculation flow; 
on the other side, part of droplet in contact with the inner arc of the channel 
prompts smaller shear, leading to a smaller recirculation flow (13). This process 
repeats along the channel, in such a way that recirculating flows vary alternately on 
each side of the drop, generating a chaos within it (13). Passive micromixers with 
chaotic advection have a promising future in microfluidic field, since they allow an 
effective mixing on a millisecond scale without requiring moving parts in devices 
(76). 
The chaotic mixing in droplet-based microfluidic devices have various 
applications such as: controlling chemical reactions (40), promoting protein 
crystallization (73) and improving biochemical analysis (78). Among the 
applications, we can emphasize the complex formation between nucleic acids and 
liposomes (Figure 2.1) as an essential step in gene delivery process. 
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Figure 2.1 - Scheme of liposomes complexation with nucleic acids within droplets 
in a droplet-based microfluidic system. Arrows represent flow within droplet.  
It is well known that cationic liposomes (positively charged) spontaneously 
make complexes with nucleic acids (negatively charged) by electrostatic 
complexation, which can be formed simply by agitation, e.g. hand-shaking or 
vortexing (22). However, the complex cationic liposomes/nucleic acids obtained in 
these processes are commonly not reproducible and exhibit high size and 
heterogeneous population, reflecting in lipoplex uptake by cells (35). Depending on 
the strategy used by cells to internalize lipoplexes, such as by endocytosis process 
(79), complexes showing small size (smaller than the endosome diameter that is 
about 200 nm) (80) and narrow size distribution (polydispersity values below 0.2) 
(81) are requested. 
In this context, researchers have been exploring the use of droplet-based 
microfluidic systems to obtain complexes with low size and polydispersity for gene 
delivery applications. For example, Ho et al. (82) showed microfluidics-assisted 
confinement in picoliter droplets to control electrostatic self-assembly between 
pDNA encoding GFP and polymeric reagents. They obtained complexes with 
approximately 300 nm in size and 0.12 of polydispersity by microfluidics, in 
contrast with approximately 400 nm in size and 0.16 of polydispersity of complexes 
obtained by the bulk method (82). In vitro assays with HEK293 cells showed that 
nanocomplexes produced in droplet-based microfluidic devices presented narrower 
size distribution, lower cytotoxicity, and higher transfection efficiency compared to 
those produced by the bulk method (82). Particularly in lipoplexes field, Hsieh et al. 
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(35) developed a picoliter incubator based on the microfluidic system, which was 
used to constantly and uniformly mix the cationic liposomes (Lipofectin composed 
of DOTMA and DOPE) with pEGFP-C1 DNA vector in a serpentine mixing region. 
The major part of the complex population generated in the microfluidic system 
presented size of approximately 200 nm and polydispersity index between 0.4 and 
0.45. On the other hand, hand-shaking generated a polydisperse complex 
exhibiting nearly three populations, one with approximately 300 nm in size, another 
with 700 nm and a third with 900 nm (35). Comparing the transfection efficiencies 
of the two complexes through GFP expression by U2OS cells, they concluded that 
complexes prepared in the microfluidic system provided more consistent gene 
transfection (coefficient of variation of 0.05) than complexes prepared by hand-
shaking (coefficient of variation of 0.30) (35). Therefore, the employment of a 
passive chaotic mixing in droplet-based microfluidic devices aiming at the nucleic 
acid incorporation in liposomes has a promising future. 
5. Droplet-based microfluidic platforms for in vitro transfection  
Besides the use for lipoplexes formation, droplet-based microfluidic platforms 
can be used to transfect cells in vitro. Transfection, the procedure to introduce 
nucleic acids into cells, can be used to study gene and protein function and 
regulation (2). Thus, cells are commonly transfected in culture systems on well 
plates for then be inserted in vivo (83,84) or only be analyzed in vitro (85). Briefly, 
there are three transfection methods: physical, biological and chemical, which are 
chosen according to cell type and purpose (2). Physical-mediated methods are 
comprised of microinjection (86), biolistic particles delivery (87), electroporation 
(88), optical gene transfection (89), sonoporation (90) and magnetic nanoparticles 
(91). Biological methods include those with virus as vector (92), chemical methods 
consist of lipid and polymeric vectors (93,94) and calcium phosphate (95). 
Transfection method is chosen in order to have high transfection efficiency, with 
safety, reproducibility, low cytotoxicity and should be easy to use (2).  
Although, when studying cellular uptake of nanoparticles for in vitro 
transfection, usually the physiologically relevant stimulus of fluid flow is overlooked 
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and internalization assays are carried out under static conditions. But, both in 
theory (96) and practice (97), it has been shown that the mechanical stimulus of 
fluid flow is an important factor to achieve an optimal transfection efficiency (98). In 
conventional transfection methods performed in wells, there is only diffusive 
transport of nanoparticles to the cellular targets surface. In microfluidic systems, a 
convective contribution can be added to the process, increasing the collision rate 
between nanoparticles and cell surface, and consequently, showing  more 
controllable and easier transfection (99).  
Thus, droplet-based microfluidic devices can be used for in vitro transfection, 
in which one droplet defines a picoliter compartment that allows single cell 
encapsulation and in vitro expression of genes, using fewer reagent than 
conventional methods (11). Microfluidic environment also offers unique possibility 
to mimic dynamic conditions, opening new possibilities to investigate. So, 
processes and techniques used in gene delivery, such as used in physical 
methods, can be better controlled and optimized in the micro-scaled environment 
(8). To summarize, we made a comparative table showing differences between 
both, conventional transfection in wells and in microfluidic systems (Table 2.1).  
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Table 2.1 - Comparative table summarizing differences between in vitro 
transfection by conventional transfection in wells and by droplet-based microfluidic 
systems. 
 
 
 
 
 
Conventional transfection 
in wells 
Droplet-based microfluidic 
systems 
Operation Fast and easy  
Slow (employ low flows) and 
require microfluidic knowledge 
Reagents Large quantity Little quantity 
Accuracy 
Detect only large quantities 
of biomarkers 
Able to detect little quantities of 
biomarkers 
Transfection 
efficiency 
Measured at the end Real-time measurement 
Nucleic acids 
transport to cells 
Diffusion Diffusion and chaotic advection 
Analysis Cell population Single cell 
 
Microfluidics, and more specifically, cell transfection inside microchannels for 
parameters analysis, is a current topic. As a result, in the last decade, many 
patents involving these issues were filed. For example, cells can be merged in 
microfluidic devices developed for handle cell with electroporation and 
electrofusion (100,101) or they can be analyzed and sorted individually by 
measuring the signal of an optical-detectable molecule (102,103). Thus, the 
integration of these steps can create a biological environment similar to those 
presented on macroscopic scale, but with advantageous engineering features of 
the microscopic format. Like explained previously, droplet microfluidics provides 
some advantages that are particularly important for in vitro cell transfection such 
as: the laminar flow behavior that improve heat and mass transfer phenomena (9), 
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the higher sensibility for biomarker that amplify the detection of extremely low 
levels of biomarker molecules (12,104), the rapid mixing of reagents in case of 
droplets applied as micromixers in which a chaotic advection contribution can be 
added to the system (40,104), the compartmentalization that reduces the 
interaction of reagents from different droplets and let an easy parallelization of 
independent experiments (14). 
From the point of view of the in vitro transfection, droplets in microfluidic 
systems can be applied as single cells compartment. Some patents have been 
published about cells encapsulation one by one in droplets, independent of cells 
densities (105). Or also encapsulate cells in nested labeled matrices, which can be 
compared to cell tissues, enabling to track or identify different cell populations 
(106). Thus, in a similar way to molecule assays, single cells analysis in this type of 
system allows a rapid detection of cell-secreted molecules, due to the low volume 
surrounding each encapsulated cell. Moreover, as the risk of cross-contamination 
decreases, cells can be analyzed by various techniques mainly by fluorescence 
detection (12). Furthermore, fluorescence detection can be applied for both 
adherent and non-adherent single cells, enabling the manipulation of isolated 
single cells and also the investigation of contents from disrupted single cells (107). 
For example, Huebner et al. (108) described the preparation of microdroplets 
containing few or individual cells to detect fluorescent protein expression by cells 
while measure droplet size, fluorescence and cell occupancy. Equally important is 
the possibility to carry out spot-checks of single cells in the time courses, since the 
response of cell population at the end, not always describes the behavior of a 
single cell in certain times (9). This technology lets us to obtain more data about 
transfection characteristics, like the real point when transfection started, the ideal 
cell lines to be used in a transfection with a specific nucleic acid and delivery 
system. To verify the potential utility of this technique, Schmitz et al. (109) used 
drop spots devices to monitor the levels of β-galactosidase in a population of single 
yeasts using the reporter enzyme fluorescence technology and also to monitor 
yeast growth rates. Boedicker et al. (110) showed another important application for 
this technique: rapid detection and drug susceptibility screening of bacteria in 
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samples without pre-incubation, that can likely generate rapid and effective patient-
specific treatment of bacterial infections. They determined the antibiogram of 
methicillin-resistant Staphylococcus aureus (MRSA), an antibiotic sensitivity strain, 
against many antibiotics. They measured the minimal inhibitory concentration 
(MIC) of the drug cefoxitin against MRSA and also signalized sensitive and 
resistant strain of S. aureus in complex samples, like human blood plasma (110).  
On the other hand, hydrogel droplets can be used to mimic in vitro 
multicellular organisms providing a 3D microenvironment for adherent and non-
adherent mammalian cells. In contrast to vast majority of in vitro cell biology 
studies, which are performed using cell monolayers cultured on flat substrates, 3D 
microenvironment recapitulates the architecture of living tissues and involves a 
dynamic interplay between biochemical and mechanical signals provided by the 
extracellular matrix (ECM), cell–cell interactions and soluble factors (111,112). 
These hydrogel droplets, composed by natural or synthetic polymers, should 
provide cells attachment and proliferation (113). Adherent cells need relatively 
resistant substrates, like collagen, to anchor and pull on their surroundings, since 
they are dependent on myosin-based contractility and cellular adhesion (114). 
Moreover, hydrogels can be engineered to promote efficient gene transfer with 
non-viral vectors (115) and can be also used to investigate cellular pathways to 
internalize nanoparticles (116). Dhaliwal et al. (115) identified extracellular matrix 
(ECM) proteins and their combinations as a microenvironment that significantly 
enhance mouse mesenchymal stem cells (mMSCs) transgene expression. They 
showed that proteins that enhanced cell proliferation and spreading, increased cell 
gene expression as well (115). Additionally, studying transgene expression 
pathway,  Dhaliwal et al. (117) showed that RhoGTPases, which mediate the 
crosstalk between cell and fibronectin (structural component of ECM), regulate 
internalization and effective intracellular processing of nanovectors, resulting in 
efficient gene transfer.    
However, there are some drawbacks that have to be taken into account 
before encapsulate cells, particularly when using robust analysis over longer 
periods of time, like how to maintain viability of cells within the droplets, risks of 
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coalescence, nutrient depletion or the accumulation of toxic metabolites (12). Thus, 
to minimize these obstacles by preventing droplet coalescence, biocompatible 
surfactant-oil formulations that allow oxygen diffusion and prevent molecules 
leaking out into the oil phase have been developed (118–123). Clausell-Tormos et 
al. (118) demonstrated the feasibility of using this strategy for long periods by 
culturing adherent and non-adherent mammalian cells into aqueous microdroplets 
of water-in-oil emulsion systems for up to two weeks. They applied the technique of 
spot-checks to analyze cells viability in the device and they also broke the 
emulsions to recover cells after a couple of days. 
In the case of microfluidic droplets, that involves immiscible phases, other 
important topics to be considered are the dominant physical mechanisms related 
with microfluidic scales, such as surface tension and diffusion. Our research group 
(124) explored these parameters, coupled with quantitative measurements within 
droplets, for the purpose of advance biological science and technology. Hence, in 
order to keep a droplet stationary for long term observation and to provide 
combinatorial measurements on a single image, Fradet et al. (125) combined rails 
and anchors in microfluidic system with laser forcing, enabling the creation of 
highly controllable 2D droplet arrays. Additionally, in microfluidic droplet systems a 
more rapid mass transfer can be expected than in single-phase microfluidic 
systems, since the interfacial area ratio between different fluids per unit volume is 
larger (126). Then, Abbyad et al. (127) applied this rails and anchors design to 
control the transport oxygen for cell cultures or to induce a temporal or spatial 
variation of gas content in droplets, thus verifying the polymerization of intracellular 
hemoglobin by deoxygenating droplets that encapsulate red blood cells from 
patients suffering from sickle cell disease.  
Furthermore, with microfluidic systems we can investigate how the shear 
stress induced by flow can affect the transfection efficiency. Shin et al. (128) 
described a microfluidic device to investigate shear stress effect upon transfection 
efficiency of liposomes/DNA complexes in primary cultured neurons, achieving 
45% of transfection. Particularly in droplet-based systems, the phenomenon of 
mixing that accelerate mass transport inside droplets is highly studied by 
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computational (129–131) or experimental instruments (73,74,132). Kinoshita et al. 
(133) used a high-speed confocal micro-particle image velocimetry (PIV) to 
measure the droplet internal flow, concluding that a three-dimensional and complex 
circulating flow is formed inside the droplet. Therefore, to correlate the 
hydrodynamic effect of mixing inside droplets to the transfection efficiency is still a 
challenge, because of the complexity of circulating flow inside the droplets. 
Nevertheless, droplet-based tools for single-cell analysis draw attention of 
many researchers for in vitro cell transfection, mainly due to the potential of high-
throughput screening and the benefits of enclosed individual microchambers (12). 
Moreover, Chinese hamster ovary (CHO) cells are widely used as cell line model 
for this application. CHO cells are the most popular host to express stably or 
transiently recombinant therapeutic proteins (134). There are many advantages for 
using CHO cells as protein expression system (135,136). One is that regulatory 
agencies like the FDA tends to easier approve recombinant proteins produced from 
CHO cells, since this cell line showed to be safe hosts for the past two decades. 
Another advantage is that CHO cells are a powerful gene amplification system, 
which grows to high cell densities in suspension and can be easily transfected. 
This cell line has also the capacity to adapt to the growth in serum free media, 
suitable characteristic for transfection by nanovectors. At last, there are some CHO 
cell strains that produce recombinant proteins with glycoforms that are compatible 
with bioactive in humans (135,136). Additionally, to previously inquire cell lines in 
their ability to express recombinant proteins, the green fluorescent protein (GFP) is 
often used as a model assay. GFP with its small size, formidable stability and 
relative ease of use, can report great exploratory results before cell line use for a 
target protein production (137). In this context, we summarize in Table 2.2 different 
methods to transfect single cells using droplet-based microfluidic platforms. In 
these microsystems, cells are placed in contact with nucleic acids inside droplets 
and physic or chemical transfection methods can be used to provide nucleic acids 
insertion inside cells.   
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Table 2.2 - Description of different methods (electroporation, microinjection and 
nanoparticles) to provide single-cell transfection in droplet-based microfluidics 
platforms. 
Transfection 
methods 
Description References 
Electroporation 
Delivery genes into cells by applying an 
external electric field, with lower voltages 
compared to conventional electroporation. 
Advantage: Higher transfection efficiency  
Disadvantage: Lower cell viability 
(138), (139) 
Microinjection 
Microneedles are used to inject nucleic acids 
and others bioactive compounds into the 
same target single-cell.  
Advantage: Quantitative introduction of 
multiple components into the same cell 
Disadvantage: Technical skills are required 
to prevent cell damage 
(140) 
Nanoparticles 
Nanoparticles as non-viral vectors for safely 
and reproducible gene delivery into cells. 
Advantage: Higher cell viability 
Disadvantage: Lower transfection efficiency 
(141), (142), (143) 
 
The most commonly transfection in droplet-based microfluidic devices is the 
electrotransfection, which is a method for delivering genes into cells by applying an 
external electric field. Due to the compartmentalization, droplet systems require 
much lower voltages compared to conventional electroporation, thus enabling a 
higher cell viability (8). Zhan et al. (138) demonstrated a simple microfluidic device 
that encapsulated cells into aqueous droplets in oil flow and then electroporated 
the encapsulated cells. The results showed an enhancement in delivering green 
fluorescent protein (EGFP) plasmid into CHO-K1, reaching approximately 11% of 
transfected cells. Thus, to demonstrate the potentiality of this transfection method 
in other cells,  Luo et al. (139) showed that fluorescein could be introduced into 
yeast cells by applying a low alternating current voltage to a couple of Au 
microelectrodes.   
Additionally, microinjection can be used to transfect cells in air-liquid droplet 
systems, enabling the introduction of multiple bioactive compounds, including 
nucleic acids, into the same target single-cells, which are difficult to handle in 
conventional methods (144). Thus,  Lee et al. (140) showed the feasibility of a 
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microinjector by engaging a microvalve in a microfluidic device to form a droplet at 
the microneedle tip allowing, for example, gene delivery in single-cells.   
In a similar way, nanoparticles, generally composed by biopolymers or lipids, 
can be used as non-viral vectors for safely and reproducible gene delivery into 
cells. Chen and co-workers (141) transfected CHO-K1 cells with a plasmid 
encoding EGFP, by a chemical stimulus, PolyFect (activated-dendrimers) 
complexed with pDNA, reaching 25% of transfection efficiency. We highlighted two 
relevant points shown in the referred work, the first important point is the necessity 
to use fluorocarbon oils as continuous phase due to their biocompatibility with cells 
and smaller loss of nanoparticles from aqueous to oil phase. The second point is 
that smaller droplets provide an increase in efficiency transfection probably 
because of a better interaction between cell and complexes (141). Likewise, 
Hufnagel et al. (142) transfected CHO-K1 cells with the same reporter gene, 
pEGFP, but using polyplexes as nanovectors, achieving 20% of transfection 
efficiency. Even though, this work approaches a modular microfluidic system that 
allows several operations with cells inside it, such as seeding, cultivation, 
manipulation, detachment, collection, encapsulation and transfection (142). 
Therefore, microdroplets systems for cells transfection is a promising future, since 
many parameters can be investigate by them in order to approximate to in vivo 
transfection conditions and also to better understand the transfection process by 
single-cell analysis.  
6. References 
1.  Perrie Y, Frederik PM, Gregoriadis G. Liposome-mediated DNA vaccination: 
the effect of vesicle composition. Vaccine. 2001;19(23–24):3301–10.  
2.  Kim TK, Eberwine JH. Mammalian cell transfection: The present and the 
future. Anal Bioanal Chem. 2010;397(8):3173–8.  
3.  Verma IM, Weitzman MD. Gene therapy: twenty-first century medicine. Annu 
Rev Biochem. 2005;74:711–38.  
4.  Tavernier G, Andries O, Demeester J, Sanders NN, De Smedt SC, Rejman 
J. mRNA as gene therapeutic: How to control protein expression. J Control 
Release. 2011;150(3):238–47.  
49 
 
 
5.  Serikawa T, Kikuchi A, Sugaya S, Suzuki N, Kikuchi H, Tanaka K. In vitro 
and in vivo evaluation of novel cationic liposomes utilized for cancer gene 
therapy. J Control Release. 2006;113(3):255–60.  
6.  Hsieh AT-H, Hori N, Massoudi R, Pan PJ-H, Sasaki H, Lin YA, et al. Nonviral 
gene vector formation in monodispersed picolitre incubator for consistent 
gene delivery. Lab Chip. The Royal Society of Chemistry; 2009;9(18):2638–
43.  
7.  Nie Z, Xu S, Seo M, Lewis PC, Kumacheva E. Polymer particles with various 
shapes and morphologies produced in continuous microfluidic reactors. J Am 
Chem Soc. 2005;127(22):8058–63.  
8.  Kim J, Hwang I, Britain D, Chung TD, Sun Y, Kim D-H. Microfluidic 
approaches for gene delivery and gene therapy. Lab Chip. The Royal 
Society of Chemistry; 2011;11(23):3941–8.  
9.  Schaerli Y, Hollfelder F. The potential of microfluidic water-in-oil droplets in 
experimental biology. Mol Biosyst. The Royal Society of Chemistry; 
2009;5(12):1392–404.  
10.  Bringer MR, Gerdts CJ, Song H, Tice JD, Ismagilov RF. Microfluidic systems 
for chemical kinetics that rely on chaotic mixing in droplets. Philos Trans R 
Soc London A Math Phys Eng Sci. The Royal Society; 
2004;362(1818):1087–104.  
11.  Kintses B, van Vliet LD, Devenish SRA, Hollfelder F. Microfluidic droplets: 
new integrated workflows for biological experiments. Curr Opin Chem Biol. 
2010;14(5):548–55.  
12.  Lindstrom S, Andersson-Svahn H. Overview of single-cell analyses: 
microdevices and applications. Lab Chip. The Royal Society of Chemistry; 
2010;10(24):3363–72.  
13.  Teh S-Y, Lin R, Hung L-H, Lee AP. Droplet microfluidics. Lab Chip. 
2008;8(2):198–220.  
14.  Song H, Chen DL, Ismagilov RF. Reactions in Droplets in Microfluidic 
Channels. Angew Chemie Int Ed. WILEY-VCH Verlag; 2006;45(44):7336–56.  
15.  Cavazzana-Calvo M, Hacein-Bey S, Basile G de Saint, Gross F, Yvon E, 
Nusbaum P, et al. Gene Therapy of Human Severe Combined 
Immunodeficiency (SCID)-X1 Disease. Science. 2000;288(5466):669–72.  
16.  Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay 
J-P, et al. Sustained Correction of X-Linked Severe Combined 
Immunodeficiency by ex Vivo Gene Therapy. N Engl J Med. 
2002;346(16):1185–93.  
17.  Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, 
50 
 
 
McIntyre E, et al. A serious adverse event after successful gene therapy for 
X-linked severe combined immunodeficiency. N Engl J Med. 
2003;348(3):255–6.  
18.  The, Journal, of, Gene, Medicine. Gene Therapy Clinical Trials Worldwide. 
John Wiley and Sons; 2015. 
19.  Rosada RS, De La Torre LG, Frantz FG, Trombone AP, Zarate-Blades CR, 
Fonseca DM, et al. Protection against tuberculosis by a single intranasal 
administration of DNA-hsp65 vaccine complexed with cationic liposomes. 
BMC Immunol. 2008;9:38.  
20.  Balbino TA, Gasperini AAM, Oliveira CLP, Azzoni AR, Cavalcanti LP, De La 
Torre LG. Correlation of the Physicochemical and Structural Properties of 
pDNA/Cationic Liposome Complexes with Their in Vitro Transfection. 
Langmuir. American Chemical Society; 2012;28(31):11535–45.  
21.  Miller AD. Cationic liposomes for gene therapy. Angew Chemie Int Ed. 
1998;37(13–14):1768–85.  
22.  Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, et al. 
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. 
Proc Natl Acad Sci USA. 1987;84(21):7413–7.  
23.  Vitor MT, Bergami-Santos PC, Barbuto JA, De La Torre LG. Cationic 
Liposomes as Non-viral Vector for RNA Delivery in Cancer Immunotherapy. 
Recent Pat Drug Deliv Formul. 2013;7(2):99–110.  
24.  Zhou X, Huang L. DNA transfection mediated by cationic liposomes 
containing lipopolylysine: characterization and mechanism of action. Biochim 
Biophys Acta - Biomembr. 1994;1189(2):195–203.  
25.  Hang JH, Spaete RR, Yoo BJ, Suh BS, Selby MJ, Houghton M. Methods and 
compositions for controlling translation of HCV proteins. Google Patents; 
1996.  
26.  Cortés MLD, Izquierdo MP. Suicide gene therapy system for the treatment of 
brain tumours. Google Patents; 1999.  
27.  De La Torre LG, Rosada RS, Trombone APF, Frantz FG, Coelho-Castelo 
AAM, Silva CL, et al. The synergy between structural stability and DNA-
binding controls the antibody production in EPC/DOTAP/DOPE liposomes 
and DOTAP/DOPE lipoplexes. Colloids Surfaces B Biointerfaces. 
2009;73(2):175–84.  
28.  De La Torre LG, Vitor MT, Bergami-Santos PC, Barbuto JAM. Production 
procedure of liposomes, the product so obtained and their uses. Brazil; 2013.  
29.  Barbuto JAM, Ensina LFC, Neves AR, Bergami-Santos PC, Leite KRM, 
Marques R, et al. Dendritic cell–tumor cell hybrid vaccination for metastatic 
51 
 
 
cancer. Cancer Immunol Immunother. Springer Berlin / Heidelberg; 
2004;53(12):1111–8.  
30.  Onaitis M, Kalady MF, Pruitt S, Tyler DS. Dendritic cell gene therapy. Surg 
Oncol Clin N Am. Elsevier; 2002;11(3):645–60.  
31.  Ma Y, Zhuang Y, Xie X, Wang C, Wang F, Zhou D, et al. The role of surface 
charge density in cationic liposome-promoted dendritic cell maturation and 
vaccine-induced immune responses. Nanoscale. The Royal Society of 
Chemistry; 2011;3(5):2307–14.  
32.  Vitor MT, Bergami-Santos PC, Piedade Cruz KS, Pinho MP, Marzagão 
Barbuto JA, La Torre LG De. Dendritic Cells Stimulated by Cationic 
Liposomes. J Nanosci Nanotechnol. 2016;16(1):270–9.  
33.  Vitor MT, Bergami-Santos PC, Zômpero RHF, Cruz KSP, Pinho MP, Barbuto 
JAM, et al. Cationic liposomes produced via ethanol injection method for 
dendritic cell therapy. J Liposome Res. 2016;7:1-15. 
34.  De Haes W, Van Mol G, Merlin C, De Smedt SC, Vanham G, Rejman J. 
Internalization of mRNA lipoplexes by dendritic cells. Mol Pharm. 
2012;9(10):2942–9.  
35.  Hsieh AT-H, Pan PJ-H, Lee AP. Rapid label-free DNA analysis in picoliter 
microfluidic droplets using FRET probes. Microfluid Nanofluidics. 
2009;6(3):391–401.  
36.  Chou LY, Ming K, Chan WC. Strategies for the intracellular delivery of 
nanoparticles. Chem Soc Rev. 2011;40(1):233–45.  
37.  Whitesides GM. The origins and the future of microfluidics. Nature. 
2006;442(7101):368–73.  
38.  Beebe DJ, Mensing G a, Walker GM. Physics and applications of 
microfluidics in biology. Annu Rev Biomed Eng. 2002;4:261–86.  
39.  van den Berg A, Craighead HG, Yang P. From microfluidic applications to 
nanofluidic phenomena. Chem Soc Rev. 2010;39(3):899–900.  
40.  Song H, Tice JD, Ismagilov RF. A Microfluidic System for Controlling 
Reaction Networks in Time. Angew Chemie Int Ed. WILEY-VCH Verlag; 
2003;42(7):768–72. 
41.  Jiang X, Ng JMK, Stroock AD, Dertinger SKW, Whitesides GM. A 
miniaturized, parallel, serially diluted immunoassay for analyzing multiple 
antigens. J Am Chem Soc. 2003;125(18):5294–5.  
42.  Sia SK, Whitesides GM. Microfluidic devices fabricated in 
poly(dimethylsiloxane) for biological studies. Electrophoresis. 
2003;24(21):3563–76.  
52 
 
 
43.  Zhang C, Xu J, Ma W, Zheng W. PCR microfluidic devices for DNA 
amplification. Biotechnol Adv. 2006;24(3):243–84.  
44.  Lagally ET, Simpson PC, Mathies R a. Monolithic integrated microfluidic 
DNA amplification and capillary electrophoresis analysis system. Sensors 
Actuators, B Chem. 2000;63(3):138–46.  
45.  Atencia J, Cooksey G a, Locascio LE. A robust diffusion-based gradient 
generator for dynamic cell assays. Lab Chip. 2012;12(2):309–16.  
46.  Oliveira AF, Pelegati VB, Carvalho HF, Cesar CL, Bastos RG, de la Torre 
LG. Cultivation of yeast in diffusion-based microfluidic device. Biochem Eng 
J. 2016;105:288–95.  
47.  Majedi FS, Hasani-Sadrabadi MM, Hojjati Emami S, Shokrgozar MA, 
VanDersarl JJ, Dashtimoghadam E, et al. Microfluidic assisted self-assembly 
of chitosan based nanoparticles as drug delivery agents. Lab Chip. The 
Royal Society of Chemistry; 2013;13(2):204–7.  
48.  Yang C-HC, Huang K-SS, Chang J-YY. Manufacturing monodisperse 
chitosan microparticles containing ampicillin using a microchannel chip. 
Biomed Microdevices. 2007;9(2):253–9.  
49.  Balbino TA, Aoki NT, Gasperini AAM, Oliveira CLP, Azzoni AR, Cavalcanti 
LP, et al. Continuous flow production of cationic liposomes at high lipid 
concentration in microfluidic devices for gene delivery applications. Chem 
Eng J. 2013;226(0):423–33.  
50.  Jahn A, Vreeland WN, DeVoe DL, Locascio LE, Gaitan M. Microfluidic 
Directed Formation of Liposomes of Controlled Size. Langmuir. American 
Chemical Society; 2007;23(11):6289–93.  
51.  Teh S-Y, Khnouf R, Fan H, Lee AP. Stable, biocompatible lipid vesicle 
generation by solvent extraction-based droplet microfluidics. Biomicrofluidics. 
2011;5(4):44113.  
52.  Lazarus LL, Yang AS-J, Chu S, Brutchey RL, Malmstadt N. Flow-focused 
synthesis of monodisperse gold nanoparticles using ionic liquids on a 
microfluidic platform. Lab Chip. 2010;10(24):3377–9.  
53.  Kim JA, Cho K, Shin YS, Jung N, Chung C, Chang JK. A multi-channel 
electroporation microchip for gene transfection in mammalian cells. Biosens 
Bioelectron. 2007;22:3273–7.  
54.  de la Torre LG, Balbino TA, C. SC, Vitor MT, Oliveira AF. Trends on 
Microfluidic Liposome Production through Hydrodynamic Flow- Focusing and 
Microdroplet Techniques for Gene Delivery Applications. In: Advances in 
Liposomes Research. 2014. p. 195.  
55.  Nge PN, Rogers CI, Woolley AT. Advances in microfluidic materials, 
53 
 
 
functions, integration, and applications. Chem Rev. 2013;113(4):2550–83.  
56.  McDonald JC, Whitesides GM. Poly ( dimethylsiloxane ) as a Material for 
Fabricating Microfluidic Devices. Acc Chem Res. 2002;35(7):491–9.  
57.  Christopher GF, Anna SL. Microfluidic methods for generating continuous 
droplet streams. J Phys D Appl Phys. 2007;40(19):R319.  
58.  Seemann R, Brinkmann M, Pfohl T, Herminghaus S. Droplet based 
microfluidics. Reports Prog Phys. 2012;75(1):16601.  
59.  Abate AR, Lee D, Do T, Holtze C, Weitz D a. Glass coating for PDMS 
microfluidic channels by sol-gel methods. Lab Chip. 2008;8(4):516–8.  
60.  Atencia J, Beebe DJ. Controlled microfluidic interfaces. Nature. 2005 Sep 
29;437(7059):648–55. 
61.  Casadevall i Solvas X, deMello A. Droplet microfluidics: recent developments 
and future applications. Chem Commun. The Royal Society of Chemistry; 
2011;47(7):1936–42.  
62.  Bibette J, Calderon FL, Poulin P. Emulsions: basic principles. Reports Prog 
Phys. 1999;62(6):969.  
63.  Taylor G. Dispersion of Soluble Matter in Solvent Flowing Slowly through a 
Tube. Proc R Soc London Ser A Math Phys Sci. 1953;219(1137):186–203.  
64.  Gu H, Duits MHG, Mugele F. Droplets formation and merging in two-phase 
flow microfluidics. Int J Mol Sci. 2011;12(4):2572–97.  
65.  Baroud CN, Gallaire F, Dangla RR. Dynamics of microfluidic droplets. Lab 
Chip. The Royal Society of Chemistry; 2010;10(16):2032–45.  
66.  Zhao C-X, He L, Qiao SZ, Middelberg APJ. Nanoparticle synthesis in 
microreactors. Chem Eng Sci. 2011;66(7):1463–79.  
67.  Baret J-C. Surfactants in droplet-based microfluidics. Lab Chip. 
2012;12(3):422.  
68.  Wagner O, Thiele J, Weinhart M, Mazutis L, David A. Weitz C, Huckb WTS, 
et al. Biocompatible fluorinated polyglycerols for droplet microfluidics as an 
alternative to PEGbased copolymer surfactants. Lab Chip. 2015;1–5.  
69.  Li D. Encyclopedia of microfluidics and nanofluidics. Springer Science & 
Business Media; 2008.  
70.  Umbanhowar PB, Prasad V, Weitz DA. Monodisperse emulsion generation 
via drop break off in a coflowing stream. Langmuir. 2000;16(2):347–51.  
71.  Hessel V, Löwe H, Schönfeld F. Micromixers—a review on passive and 
active mixing principles. Chem Eng Sci. 2005;60(8):2479–501.  
54 
 
 
72.  Kim DS, Lee SH, Kwon TH, Ahn CH. A serpentine laminating micromixer 
combining splitting/recombination and advection. Lab Chip. 2005;5(7):739–
47.  
73.  Zheng B, Tice JD, Ismagilov RF. Formation of droplets of alternating 
composition in microfluidic channels and applications to indexing of 
concentrations in droplet-based assays. Anal Chem. 2004;76(17):4977–82.  
74.  Tice JD, Lyon AD, Ismagilov RF. Effects of viscosity on droplet formation and 
mixing in microfluidic channels. Anal Chim Acta. 2004;507(1):73–7.  
75.  de Lozar A, Hazel AL, Juel A. Scaling properties of coating flows in 
rectangular channels. Phys Rev Lett. 2007;99(23):234501.  
76.  Nguyen N-T. Micromixers: fundamentals, design and fabrication. William 
Andrew; 2011.  
77.  Ho C-M. Micro/nano technology systems for biomedical applications: 
microfluidics, optics, and surface chemistry. Oxford University Press; 2010.  
78.  Brouzes E, Medkova M, Savenelli N, Marran D, Twardowski M, Hutchison 
JB, et al. Droplet microfluidic technology for single-cell high-throughput 
screening. Proc Natl Acad Sci. 2009 Aug 25;106(34):14195–200.  
79.  Colosimo A, Serafino A, Sangiuolo F, Di Sario S, Bruscia E, Amicucci P, et 
al. Gene transfection efficiency of tracheal epithelial cells by DC-Chol–
DOPE/DNA complexes. Biochim Biophys Acta (BBA)-Biomembranes. 
1999;1419(2):186–94.  
80.  Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization 
of particles via the pathways of clathrin- and caveolae-mediated endocytosis. 
Biochem J. 2004;377(Pt 1):159–69.  
81.  Muthu MS, Kulkarni SA, Raju A, Feng SS. Theranostic liposomes of TPGS 
coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials. 
2012;33(12):3494–501.  
82.  Ho Y-P, Grigsby CL, Zhao F, Leong KW. Tuning Physical Properties of 
Nanocomplexes through Microfluidics-Assisted Confinement. Nano Lett. 
American Chemical Society; 2011;11(5):2178–82.  
83.  Itaka K, Uchida S, Matsui A, Yanagihara K, Ikegami M, Endo T, et al. Gene 
transfection toward spheroid cells on micropatterned culture plates for 
genetically-modified cell transplantation. JoVE (Journal Vis Exp. 
2015;(101):e52384–e52384.  
84.  Wurm FM. Production of recombinant protein therapeutics in cultivated 
mammalian cells. Nat Biotechnol. 2004;22(11):1393–8.  
85.  Nikić I, Kang JH, Girona GE, Aramburu IV, Lemke EA. Labeling proteins on 
55 
 
 
live mammalian cells using click chemistry. Nat Protoc. 2015;10(5):780–91.  
86.  Cottle RN, Lee CM, Archer D, Bao G. Controlled delivery of β-globin-
targeting TALENs and CRISPR/Cas9 into mammalian cells for genome 
editing using microinjection. Sci Rep. 2015;5.  
87.  Drummond MC, Barzik M, Bird JE, Zhang D-S, Lechene CP, Corey DP, et al. 
Live-cell imaging of actin dynamics reveals mechanisms of stereocilia length 
regulation in the inner ear. Nat Commun. 2015;6.  
88.  Takahashi M, Kikkawa T, Osumi N. Gene transfer into cultured mammalian 
embryos by electroporation. Electroporation Methods Neurosci. 2015;141–
57.  
89.  Uchugonova A, Breunig HG, Batista A, König K. Optical reprogramming with 
ultrashort femtosecond laser pulses. In: SPIE BiOS. International Society for 
Optics and Photonics; 2015. p. 93290U–93290U–6.  
90.  Wang Y, Chen Y, Zhang W, Yang Y, Bai W, Shen E, et al. Upregulation of 
ULK1 expression in PC‑3 cells following tumor protein P53 transfection by 
sonoporation. Oncol Lett. 2016;11(1):699–704.  
91.  Shi W, Liu X, Wei C, Xu ZJ, Sim SSW, Liu L, et al. Micro-optical coherence 
tomography tracking of magnetic gene transfection via Au–Fe 3 O 4 
dumbbell nanoparticles. Nanoscale. 2015;7(41):17249–53.  
92.  Tokunaga Y, Liu D, Nakano J, Zhang X, Nii K, Go T, et al. Potent effect of 
adenoviral vector expressing short hairpin RNA targeting ribonucleotide 
reductase large subunit M1 on cell viability and chemotherapeutic sensitivity 
to gemcitabine in non-small cell lung cancer cells. Eur J Cancer. 
2015;51(16):2480–9.  
93.  Bartman CM, Egelston J, Ren X, Das R, Phiel CJ. A simple and efficient 
method for transfecting mouse embryonic stem cells using polyethylenimine. 
Exp Cell Res. 2015;330(1):178–85.  
94.  Zhang L. Polymeric nanoparticle-based delivery of microRNA-199a-3p 
inhibits proliferation and growth of osteosarcoma cells. Int J Nanomedicine. 
2015;10:2913.  
95.  Mostaghaci B, Susewind J, Kickelbick G, Lehr C-M, Loretz B. Transfection 
System of Amino-Functionalized Calcium Phosphate Nanoparticles: In Vitro 
Efficacy, Biodegradability, and Immunogenicity Study. ACS Appl Mater 
Interfaces. 2015;7(9):5124–33.  
96.  Decuzzi P, Ferrari M. Design maps for nanoparticles targeting the diseased 
microvasculature. Biomaterials. 2008;29(3):377–84.  
97.  Farokhzad OC, Khademhosseini A, Jon S, Hermmann A, Cheng J, Chin C, 
et al. Microfluidic system for studying the interaction of nanoparticles and 
56 
 
 
microparticles with cells. Anal Chem. American Chemical Society; 
2005;77(17): 5453-59.  
98.  Meer van der AD, Kamphuis MMJ, Poot AA, Feijen J, Vermes I. A 
microfluidic device for monitoring siRNA delivery under fluid flow. J Control 
Release. 2008;132(3):e42–4.  
99.  Harris SS, Giorgio TD. Convective flow increases lipoplex delivery rate to in 
vitro cellular monolayers. Gene Ther. 2005;12(6):512–20.  
100.  Fuhr G, Gradl G, Mueller T, Schnelle T, Shirley SG. Microsystem for cell 
permeation and cell fusion. Google Patents; 2000.  
101.  Lee LP, Seo J, Ionescu-Zanetti C, Khine M, Lau A. Cell handling, 
electroporation and electrofusion in microfluidic systems. Google Patents; 
2012.  
102.  Quake S, Volksmuth W. Method and apparatus for analysis and sorting of 
polynucleotides based on size. Google Patents; 2006.  
103.  Ata E, Esener S, Wang M. Optical switching and sorting of biological 
samples and microparticles transported in a micro-fluidic device, including 
integrated bio-chip devices. Google Patents; 2002.  
104.  Song H, Ismagilov RF. Millisecond Kinetics on a Microfluidic Chip Using 
Nanoliters of Reagents. J Am Chem Soc. American Chemical Society; 
2003;125(47):14613–9. 
105.  Lee A, Fisher J. Microfluidic device for the encapsulation of cells with low 
and high cell densities. Google Patents; 2006.  
106.  Choo Y, Johnson CJ, Odenwälder PK, Jayasinghe SN. Nested cell 
encapsulation. Google Patents; 2012. 
107.  Sims CE, Allbritton NL. Analysis of single mammalian cells on-chip. Lab 
Chip. The Royal Society of Chemistry; 2007;7(4):423–40.  
108.  Huebner A, Srisa-Art M, Holt D, Abell C, Hollfelder F, deMello AJ, et al. 
Quantitative detection of protein expression in single cells using droplet 
microfluidics. Chem Commun. The Royal Society of Chemistry; 
2007;(12):1218–20.  
109.  Schmitz CHJ, Rowat AC, Köster S, Weitz DA. Dropspots: a picoliter array in 
a microfluidic device. Lab Chip. 2009;9(1):44–9.  
110.  Boedicker JQ, Li L, Kline TR, Ismagilov RF. Detecting bacteria and 
determining their susceptibility to antibiotics by stochastic confinement in 
nanoliter droplets using plug-based microfluidics. Lab Chip. 2008;8(8):1265–
72.  
57 
 
 
111.  Alessandri K, Sarangi BR, Gurchenkov VV, Sinha B, Kießling TR, Fetler L, et 
al. Cellular capsules as a tool for multicellular spheroid production and for 
investigating the mechanics of tumor progression in vitro. Proc Natl Acad Sci. 
2013;110(37):14843–8.  
112.  Ranga A, Gobaa S, Okawa Y, Mosiewicz K, Negro A, Lutolf MP. 3D niche 
microarrays for systems-level analyses of cell fate. Nat Commun. 2014;5.  
113.  Fedorovich NE, Alblas J, de Wijn JR, Hennink WE, Verbout AJ, Dhert WJA. 
Hydrogels as extracellular matrices for skeletal tissue engineering: state-of-
the-art and novel application in organ printing. Tissue Eng. 2007;13(8):1905–
25.  
114.  Discher DE, Janmey P, Wang Y. Tissue cells feel and respond to the 
stiffness of their substrate. Science. 2005;310(5751):1139–43.  
115.  Dhaliwal A, Lam J, Maldonado M, Lin C, Segura T. Extracellular matrix 
modulates non-viral gene transfer to mouse mesenchymal stem cells. Soft 
Matter. 2012;8(5):1451–9.  
116.  Mih JD, Marinkovic A, Liu F, Sharif AS, Tschumperlin DJ. Matrix stiffness 
reverses the effect of actomyosin tension on cell proliferation. J Cell Sci. 
2012;125(Pt 24):5974–83. 
117.  Dhaliwal A, Maldonado M, Lin C, Segura T. Cellular cytoskeleton dynamics 
modulates non-viral gene delivery through RhoGTPases. PLoS One. 
2012;7(4):e35046.  
118.  Clausell-Tormos J, Lieber D, Baret J-C, El-Harrak A, Miller OJ, Frenz L, et al. 
Droplet-Based Microfluidic Platforms for the Encapsulation and Screening of 
Mammalian Cells and Multicellular Organisms. Chem Biol. Cell Press; 
2008;15(5):427–37.  
119.  Courtois F, Olguin LF, Whyte G, Theberge AB, Huck WTS, Hollfelder F, et al. 
Controlling the Retention of Small Molecules in Emulsion Microdroplets for 
Use in Cell-Based Assays. Anal Chem. American Chemical Society; 
2009;81(8):3008–16.  
120.  Courtois F, Olguin LF, Whyte G, Bratton D, Huck WTS, Abell C, et al. An 
Integrated Device for Monitoring Time-Dependent in vitro Expression From 
Single Genes in Picolitre Droplets. ChemBioChem. WILEY-VCH Verlag; 
2008;9(3):439–46. 
121.  Ghadessy FJ, Holliger P. A novel emulsion mixture for in vitro 
compartmentalization of transcription and translation in the rabbit reticulocyte 
system. Protein Eng Des Sel. 2004;17(3):201–4.  
122.  Holtze C, Rowat AC, Agresti JJ, Hutchison JB, Angile FE, Schmitz CHJ, et 
al. Biocompatible surfactants for water-in-fluorocarbon emulsions. Lab Chip. 
The Royal Society of Chemistry; 2008;8(10):1632–9.  
58 
 
 
123.  Roach LS, Song H, Ismagilov RF. Controlling Nonspecific Protein Adsorption 
in a Plug-Based Microfluidic System by Controlling Interfacial Chemistry 
Using Fluorous-Phase Surfactants. Anal Chem. American Chemical Society; 
2004;77(3):785–96.  
124.  Abbyad P, Tharaux P-L, Martin J-L, Baroud CN, Alexandrou A. Sickling of 
red blood cells through rapid oxygen exchange in microfluidic drops. Lab 
Chip. 2010;10(19):2505–12.  
125.  Fradet E, McDougall C, Abbyad P, Dangla R, McGloin D, Baroud CN. 
Combining rails and anchors with laser forcing for selective manipulation 
within 2D droplet arrays. Lab Chip. The Royal Society of Chemistry; 
2011;11(24):4228–34.  
126.  Kim DH. Microdroplets for the Study of Mass Transfer. In: Nakajima DH, 
editor. Mass Transfer - Advanced Aspects. InTech; 2011. p. 805–24.  
127.  Abbyad P, Dangla R, Alexandrou A, Baroud CN. Rails and anchors: guiding 
and trapping droplet microreactors in two dimensions. Lab Chip. The Royal 
Society of Chemistry; 2011;11(5):813–21.  
128.  Shin HS, Kim HJ, Sim SJ, Jeon NL. Shear Stress Effect on Transfection of 
Neurons Cultured in Microfluidic Devices. J Nanosci Nanotechnol. 
2009;9(12):7330–5.  
129.  Alam A, Afzal A, Kim K-Y. Mixing performance of a planar micromixer with 
circular obstructions in a curved microchannel. Chem Eng Res Des. 
2014;92(3):423–34.  
130.  Liau A, Karnik R, Majumdar A, Cate JHD. Mixing crowded biological 
solutions in milliseconds. Anal Chem. 2005;77(23):7618–25.  
131.  Muradoglu M, Stone HA. Mixing in a drop moving through a serpentine 
channel: a computational study. Phys Fluids. 2005;17(7):73305.  
132.  Tice JD, Song H, Lyon AD, Ismagilov RF. Formation of droplets and mixing 
in multiphase microfluidics at low values of the Reynolds and the capillary 
numbers. Langmuir. 2003;19(22):9127–33.  
133.  Kinoshita H, Kaneda S, Fujii T, Oshima M. Three-dimensional measurement 
and visualization of internal flow of a moving droplet using confocal micro-
PIV. Lab Chip. Royal Society of Chemistry; 2007;7(3):338–46.  
134.  Jayapal KP, Wlaschin KF, Hu W, Yap MGS. Recombinant protein 
therapeutics from CHO cells-20 years and counting. Chem Eng Prog. AICHE 
AMERICAN INSTITUTE OF CHEMICAL; 2007;103(10):40.  
135.  Hacker DL, Balasubramanian S. Recombinant protein production from stable 
mammalian cell lines and pools. Current Opinion in Structural Biology. 2016. 
p. 129–36.  
59 
 
 
136.  Kim JY, Kim Y-G, Lee GM. CHO cells in biotechnology for production of 
recombinant proteins: current state and further potential. Appl Microbiol 
Biotechnol. Springer; 2012;93(3):917–30.  
137.  March JC, Rao G, Bentley WE. Biotechnological applications of green 
fluorescent protein. Appl Microbiol Biotechnol. Springer; 2003;62(4):303–15.  
138.  Zhan Y, Wang J, Bao N, Lu C. Electroporation of Cells in Microfluidic 
Droplets. Anal Chem. American Chemical Society; 2009;81(5):2027–31.  
139.  Luo C, Yang X, Fu Q, Sun M, Ouyang Q, Chen Y, et al. Picoliter-volume 
aqueous droplets in oil: Electrochemical detection and yeast cell 
electroporation. Electrophoresis. 2006;27(10):1977–83.  
140.  Lee S, Jeong W, Beebe DJ. Microfluidic valve with cored glass microneedle 
for microinjection. Lab Chip. 2003;3(3):164–7.  
141.  Chen F, Zhan Y, Geng T, Lian H, Xu P, Lu C. Chemical transfection of cells 
in picoliter aqueous droplets in fluorocarbon oil. Anal Chem. 
2011;83(22):8816–20.  
142.  Hufnagel H, Huebner A, Gulch C, Guse K, Abell C, Hollfelder F. An 
integrated cell culture lab on a chip: modular microdevices for cultivation of 
mammalian cells and delivery into microfluidic microdroplets. Lab Chip. The 
Royal Society of Chemistry; 2009;9(11):1576–82.  
143.  Lee APICA, Hsieh AT-HICA. Microfluidic device for forming monodisperse 
lipoplexes. Google Patents; 2010.  
144.  Matsuoka H, Komazaki T, Mukai Y, Shibusawa M, Akane H, Chaki A, et al. 
High throughput easy microinjection with a single-cell manipulation 
supporting robot. J Biotechnol. 2005;116(2):185–94.  
 
 
60 
 
 
Chapter III – Droplet Microfluidic-Assisted Synthesis of 
Lipoplexes for DC Transfection 
_________________________________________________________________________ 
 
 
Micaela Tamara Vitor1,2, André Luiz Paes de Lima1, Lívia Furquim de Castro3, 
Ronei Luciano Mamoni3, Charles N. Baroud2, Lucimara Gaziola De La Torre1* 
 
 
1 School of Chemical Engineering, Department of Bioprocesses and Materials 
Engineering, University of Campinas (Unicamp), Av. Albert Einstein, 500, 
Campinas, SP, 13083-852, Brazil  
2 LadHyX and Department of Mechanics, Ecole Polytechnique, CNRS-UMR, 91128 
Palaiseau, France 
3 Department of Clinical Pathology, Faculty of Medical Sciences, University of 
Campinas (Unicamp), Rua Tessália Vieira de Camargo, 126, Campinas, SP, 
13083-887, Brazil 
 
 
*Corresponding author: latorre@feq.unicamp.br  
To be submitted to Chemical Engineering Journal  
61 
 
 
Abstract 
Dendritic cells (DCs), professional antigen-presenting cells, are widely used in 
immunotherapeutic approaches. When loaded with tumor antigens, mature DCs 
can induce an immune response against cancer. Particularly, cationic liposomes 
show as a promising gene carrier for DCs, since besides to be internalized, they 
can also activate them. However, DCs transfection dependence of lipoplexes size 
and polydispersity makes the process a challenge. In this context, droplet-based 
microfluidic system can be applied in order to obtain reproducible and suitable 
lipoplexes to DCs transfection. For this purpose, we investigated a droplet-based 
microfluidic system with serpentine and split regions to synthesize lipoplexes. We 
first investigated operational parameters that influence in droplets formation, like 
inlet flow rates. Thus, we chose to operate the system at ratio aqueous/oil flow rate 
0.25. Then, we ensured that cationic liposomes maintain their properties after 
droplet processing. We investigated the influence of molar charge ratio in 
lipoplexes formation and we also evaluated different microchip designs, exploring 
the effect of residence time and droplet size in lipoplexes physico-chemical 
properties. The droplet-based system allowed the incorporation of more amount of 
pDNA to CL while maintaining lipoplexes monodisperse and with positive charge. 
Mixing provided by small droplets flowing in the serpentine channel was more 
important than residence time to decrease lipoplexes polydispersity. Lipoplexes 
were able to transfect DCs, besides activating cells. However, lipoplexes loading 
lower amount of DNA were more efficient in transfect DCs. Thus, droplet-based 
microfluidic system showed to be a potential tool in lipoplexes properties 
modulation according to specific cell lines.  
 
Keywords: lipoplex, transfection, microfluidics, water fraction, capillary number, 
molar charge ratio  
1. Introduction 
Gene therapy is the insertion of genetic materials into cells or organs in order 
to treat genetic defects. For this, gene therapy requires safety and efficient gene 
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delivery systems, classified as viral and non-viral vectors. Viral vectors delivery 
efficiently the target gene into the host cell, but as consequence, immune and 
oncogenic responses can be activated. To overcome these drawbacks, non-viral 
vectors were developed reproducing viral gene delivery function, in a more secure 
and  reproducible way, even though without reaching the high transfection level 
verified by virus vectors (1). Within the current range of non-viral vectors, cationic 
liposomes are particularly promising (2). The electrostatic interaction between the 
positive charge of cationic lipids from liposomes and negative charges from 
phosphate groups from nucleic acids form complexes capable of entering cells, 
named lipoplexes (3). 
In the field of gene delivery, one specific challenge is the transfection of 
dendritic cells (DCs). DCs are professional antigen-presenting cells widely used in 
immunotherapeutic approaches, particularly in immunotherapies against cancer. 
Since loaded with tumor antigens, mature DCs can induce an immune response 
against cancer by recruiting patients’ immune system (4). Different strategies are 
currently used to load mature DCs in vitro with tumor antigens (5). Cationic 
liposomes stand out in this function as gene carriers, since besides to transfect 
DCs, they can also activated them (6). The cationic liposomes composed of Egg 
phosphatidylcholine (EPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
(DOPE) and 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) (50/25/25% 
molar) showed as a potential tool for DC-based immunotherapeutic approaches, 
since they were uptaken by DCs providing cell stimulation/activation (7,8). DCs 
uses preferentially macropinocytosis and/or phagocytosis as transfection pathway, 
and so, extremely dependent of lipoplexes size and polydispersity for transfection 
(9). Thus, the study of methodologies that enable to form lipoplexes modulated to 
specific cells lines in a reproducible and controllable way is very important (10).  
Conventional methods of obtaining lipoplexes involve just the mixing provided 
by hand shaking or vortexing to reach cationic liposomes complexation with nucleic 
acids. However, these conventional methods introduce variability in lipoplexes 
formation and, as a result, provide inconsistent transfection efficiencies (11). To 
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effectively transfect cells, the physico-chemical properties of lipoplexes should be 
suitable to the pathway used by the cell line to internalize nanoparticles (12).  
On the other hand, to circumvent the above difficulties, the micro-scaled 
environment of microfluidic systems allows precise control and optimization of 
multiple processes and techniques used in gene therapy (1). Droplet-based 
microfluidic systems define microcontainers that reduce of many orders the 
volumes manipulated, making these systems attractive for performing experiments 
in molecular biology. Moreover, droplets moving in microfluidic systems become 
micromixers that provide a rapid mixing of reagents (13). Microsystems working 
only with parallel streams have the fluid mixing mainly promoted by diffusion, 
whereas droplet-based microsystems can have the addition of chaotic advection 
that increases the mixing in the system (14). The chaotic advection in serpentine 
channel is generated by two recirculation flows inside droplets due to the shear 
created between droplet and channel walls (15). Micromixers have important 
applications such as control chemical reactions (16), promote protein crystallization 
(17), improve biochemical analysis (18) and complex nanoparticles and nucleic 
acids (11). Hsieh et al. (11) developed a picolitre incubator based microfluidic 
system to complex commercial liposomes lipofectin with pDNA encoding GFP. 
They showed the robusteness of the microsystem to produce reproducible 
lipoplexes and also to transfect human osteosarcoma U2OS cells (11). Thus, 
droplet-based microfluidic platforms emerge as an alternative to conventional 
methods, which provide more controllable environment for direct synthesis of 
lipoplexes adequate for gene therapy applications (19). To produce lipoplexes 
according to the cell line requirements, some parameters, such as flow rates, 
viscosity of fluids and microchip design, which influence on mixing in droplet-based 
platforms, should take into account (20,21). 
Therefore, this work aimed to investigate the complexation of 
EPC/DOTAP/DOPE liposomes with plasmidial DNA (pDNA) by droplet-based 
microfluidic system, based on microchip already designed by Hsieh et al. (11) in 
order to obtain reproducible and suitable lipoplexes to DCs transfection. For this 
purpose, some experimental parameters were investigated, such as flow rates to 
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ensure droplets formation in the system, liposomes physico-chemical properties 
after droplet processing, lipoplex characteristics as function of molar charge ratio 
(R+/-) and microchip design. Then, lipoplexes produced in the microfluidic system 
operating in the chose parameters were evaluated in their capacity to transfect 
DCs in vitro while stimulating cells.  
2. Materials and Methods  
2.1. Microfabrication 
Cationic liposomes (CLs) and lipoplexes (CL/pDNA complexes) were 
synthesized in PDMS/glass microfluidic devices fabricated according to Moreira et 
al. (22). The designs of the devices were projected using the software AutoCAD 
2002. All microchannels had a rectangular cross section constructed using soft 
lithography methods in PDMS and irreversibly sealed to glass through O2 plasma 
surface activation (22). 
The cationic liposomes production was carried out in a cross-junction 
device, like used by Balbino et al. (23) and illustrated in Figure 3.1A. Channels had 
a rectangular cross section with a depth of 100 µm and a width of 140 µm. 
Otherwise, the devices designed for lipoplexes formation (Figure 3.1B) was based 
on Hsieh et al. (11), with slight modifications. The device had rectangular cross 
section with 50 µm of depth in all channel. The serpentine channel was classified 
as: (i) thin channel (TC) with 200 µm of width (D) and 9600 µm of linear length (L), 
and (ii) wide channel (WC) with 400 µm of width (D) and 19200 µm of linear length 
(L) (Figure 3.1B). Number of curves in serpentine channel was fixed in 13 for both 
WC and TC. Mix between pDNA and CL occurred in the serpentine channel due to 
a chaotic advection (11), and so this part of the chip was used to calculate the 
average flow velocity of the system. Furthermore, droplet microfluidic device can 
have or not a split region (Figure 3.1B) in the end of the design with 50 µm of width 
to accelerate the mixing efficiency of reagents inside microdroplets (10).  
PDMS microchips bonded with glass slide by plasma oxygen rendered 
surface hydrophilic. Thus, for the use of fluorinated oil as continuous phase of the 
emulsion system (Figure 3.1B), a treatment with Novec 1700 Electronic Grade 3M 
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Coating solution (MN, USA) was done, deposing a layer of fluoropolymer in the 
inner surfaces. For this, microdevices were filled with the electronic coating 
solution and heated at 150 °C for 30 minutes; this procedure was repeated three 
times. Then, microchips were cooled in room temperature and microchannels were 
filled with pure FC-40 oil, which remained in the system until the use. 
                                A 
 
B 
Figure 3.1 - Microfluidic devices. Cross-junction device for liposome production by 
a single hydrodynamic flow focusing (A) and droplet-based device for CL 
complexation with pDNA with serpentine channel and split regions (B). The droplet-
based devices designed varying the serpentine width (thin-TC and wide-WC 
channels). TC:  200 µm of width (D) and 9600 µm of linear length (L); WC: 400 µm 
of width (D) and 19200 µm of linear length (L). The channel in the split region have 
50 m of width (devices without split region were also investigated). 
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2.2. Cationic Liposome Production  
Cationic liposomes composed of egg phosphatidylcholine (EPC) (96% of 
purity), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) (99.8% of purity) 
and 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) (98% of purity) (Lipoid 
GmbH, Ludwigshafen, Germany) (50/25/25 % molar, respectively) were produced 
by single hydrodynamic flow focusing in a cross-junction device like Balbino et al. 
(23) (Figure 3.1A). Basically, the three lipids were dispersed in anhydrous ethanol 
to achieve 25 mM of total lipid concentration. To form cationic liposomes for gene 
delivery with this lipid composition is very important the order in which lipids are 
dispersed in the alcoholic solution, the grade purity of lipids, the method used to 
form liposomes and their concentration (24). The lipid dispersion was injected as 
center flow at 10.92 μL min−1 with a glass syringe (Hamilton, NV, USA) by syringe 
pump (KDScientific, model KDS-200, USA). Simultaneously, water (Samtec, SP, 
Brazil) were inserted at 54.6 μL min−1 by two sides of cross-junction chip. Liposome 
samples were collected and leaved for at least 2 hours at 4 °C. Then, samples 
were collected to physico-chemical characterization. Before choosing water as 
aqueous phase, others biocompatible solutions, like PBS buffer and OptiMEM 
culture medium were also tested. However, cationic liposomes in water had the 
best characteristics for the specific application of DCs transfection (see Annex II). 
2.3. Lipoplexes Synthesis and Recovery from A/O Emulsion 
Aqueous flows, cationic liposomes and pDNA, and the oil flow were injected 
in their respective inlets (Figure 3.1B) by syringe pumps Harvard (model 
HA3000W, MA, USA). The oil flow (FC40/Pico-Surf 1) was composed of 
perfluorocarbon oil Fluorinert Electronic Liquid FC-40 from 3M (Zwijndrecht, 
Belgium) with 5% v/v of Pico-Surf 1 from Sphere Fluidics (Cambridge, UK). The 
pDNA used was a plasmid pEGFP-N1 from Clontech (CA, USA) encoding green 
fluorescent protein (see Annex I) that was previously amplified using competent E. 
Coli bacteria and purified (kit Maxiprep PureLink from Invitrogen, CA, USA) (25). 
During complexation, the microchip was placed over a Peltier system (Watronix, 
CA, USA) to maintain temperature at 4 °C (23). After complexation process, the 
67 
 
 
obtained emulsion was centrifuged at 10,000 rpm for 4 minutes to separate 
phases. In the supernatant of emulsion lipoplexes were recovered, for then being 
characterized in terms of physico-chemical properties and/or applied for biological 
evaluation.  
It is important to highlight that this recovered procedure by centrifugation was 
used as the last step for all process that occurred in the droplet-based microfluidic 
device in order to obtain the aqueous phase from emulsion. 
2.4. Capillary (Ca) and Reynolds (Re) Numbers 
The capillary number (Ca) is a dimensionless number that relates viscous 
forces and surface tension between two immiscible phases, as demonstrated in 
Equation 3.1. 
𝐶𝑎 =  
𝜇𝐶𝑈
𝛾
            (Equation 3.1) 
where μC is the dynamic viscosity of continuous phase, U is the average flow 
velocity and γ is the surface tension between two immiscible phases. The dynamic 
viscosity of the continuous phase (μoil = 7.43 mPa s) was obtained by analyzing the 
material in Anton Paar rheometer (model Physica MCR301, Graz, Austria). The 
surface tension (γ = 15.82 mN m-1) was obtained by pendant drop method 
performed in Teclis tensiometer (model Tracker-S, Longessaigne, France). The 
average oil flow velocity (U) was determined in the serpentine region from 
measured area section. 
In microfluidic systems only laminar regime occurs (26). Thus, we used the 
Reynolds number obtained by Equation 3.2 to investigate mixing inside droplets 
provided by the serpentine geometry.   
Re =
𝜌𝐶𝑈𝑑ℎ
𝜇𝐶
           (Equation 3.2) 
where ρC is the density of continuous phase (ρoil = 1.85 kg m
-3), U is the average 
flow velocity, dh is the hydraulic diameter (80 µm for TC or  89 µm for WC) and μC 
is the dynamic viscosity of continuous phase. 
 
68 
 
 
2.5. Physico-Chemical Characterization of Cationic Liposomes and Lipoplexes  
To characterize nanoparticles properties, the cationic liposomes and 
lipoplexes were diluted in water at 25 °C until 0.25 mM. The average hydrodynamic 
diameter, the size distribution, polydispersity index and zeta potential were 
measured by dynamic light scattering (Malvern Zetasizer Nano Series, model 
ZEN3600 - UK) using a Ne–He laser. The mean diameter and the distribution of 
particle sizes were calculated using CONTIN algorithm. Nanoparticles’ size was 
presented in number mean, number-weighted hydrodynamic mean diameter. 
Each experiment was conducted at least three times and statistical analysis 
performed with MS Excell 2007. The data was analyzed by ANOVA to compare the 
results in each group followed by Tukey's test at a p-value < 0.10. 
2.6. Biological Evaluation of Lipoplexes 
2.6.1. Generation of DCs from THP-1 Cell Line and Transfection With Lipoplexes 
THP-1 cells, derived from human monocytic leukemia cell line, were 
differentiated into dendritic cells as described by Berges et al. (27). THP-1 cells 
were cultivated in culture medium RPMI 1640 from Gibco-Invitrogen (NY, USA) 
supplemented with 0.1 M (2%) L-glutamine, fetal bovine serum (10%) and 
gentamycin (0.05%), at a concentration of 5 x 105 cells mL−1. To induce DC 
differentiation, the cytokines from Peprotech (NJ, USA) rhIL-4 (50 ng mL-1) and 
rhGM-CSF (50 ng mL-1) were added. Cells were cultured for 5 days to acquire the 
properties of immature dendritic cells (iDCs). Medium exchange was performed on 
the second day with fresh cytokine-supplemented medium. On the fifth day, iDCs 
were collected and seeded on 24-well plate in OptiMEM medium (reduced-serum 
medium from Gibco-Invitrogen, USA) for transfection. Cells were stimulated with 
cytokine rhTNF-α (50 ng mL-1) to induce mature dendritic cells (mDCs) as positive 
control, or with lipoplexes R+/- 1.5, 3, 5, 7 and 10 (2 μg pDNA / well) or cationic 
liposomes (1 mM) diluted in OptiMEM, or as negative control, no stimulant was 
added (iDC). Then, they were incubated for 3-4 hours at 37 °C and 5% CO2. 
Subsequently, liposome and lipoplexes were washed out and medium exchanged 
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by RPMI supplemented again. After this step, the DCs were incubated for more 2 
days to evaluate the transfection efficiency (TE).  
2.6.2. Flow Cytometry  
After 2 days post-transfection, dendritic cells were harvested and incubated 
for 20 min at 4°C with antibodies CD80, CD11c, CD86 and HLA-DR (Biolegend, 
CA, USA) conjugated to APC, PE-Cy5, PE and APC-Cy7, respectively. After 
incubation, cells were washed, fixed (2% paraformaldehyde) and the samples were 
acquired in a Flow Cytometer (FACScanto, BD Biosciences, CA, USA). At least 
10,000 events were acquired per sample. The data was analyzed using the FlowJo 
7.6 software (Tree Star, Inc., CA, USA). Cells were marked with anti-CD11c and 
anti-HLA-DR to identify dendritic cells in the population (see strategy of DCs 
analysis in Supplementary data, Figure S.2). The other antibodies, anti-CD80 and 
anti-CD86, were used in order to determinate DCs activation. Then, transfection 
efficiency was indirectly measured by quantification of GFP production through 
FITC fluorescence filter (see strategy of GFP analysis in Supplementary data, 
Figure S.3), procedure widely used for exploratory results of transfection (28).  
3. Results and Discussion  
3.1. Establishment of the best condition for droplet generation 
The first step was the establishment of processing conditions ensuring droplet 
formation with suitable performance and shape in the microfluidic device with 
serpentine (TC) and split regions. For this, we determined the capacity of droplet 
generation as function of aqueous flow rate (Qaqueous), containing only CLs, to 
reach the best inlet flow rates in which droplets were formed. The oil phase was 
composed by FC40/Pico-Surf 1 solution, with flow rate fixed at (Qoil) fixed at 2 μL 
min−1. In this situation, the assays were performed at 25 °C with Ca fixed at 3x10-3. 
Previous study determined Qaqueous range used in this work (see Annex II).  
Thus, Figure 3.2 illustrates some different flow regimes as function of Qaqueous. 
Considering the nondimensional drop size (λ), ratio of the droplet size to the 
serpentine channel width (20), in Qaqueous range between 0.22 and 0.47 μL min
−1 
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was formed small droplets (Figure 3.2A) with λ = 0.82. Droplets formed in     
Qaqueous = 0.50 μL min
−1 matched λ = 1.31, i.e. almost 1.5 times the width of the 
channel (Figure 3.2B). On the other hand, in Qaqueous between 0.53 and 1.33 μL 
min−1 (Figure 3.2C) were formed plugs (26) of λ = 2.10. At last, in Qaqueous above 
2.00 μL min−1 (Figure 3.2D) streams flowed in parallel. Thus, investigating the 
droplets size and shorter operating time, we chose the follow flow rates Qaqueous = 
0.50 μL min−1 and Qoil= 2 μL min
−1 (Figure 3.2B) to form droplets in microchip with 
serpentine TC and split region. For further steps we fixed the volume fraction, ratio 
between Qaqueous and Qoil, at 0.25.   
     A                           B                           C                           D 
 
Figure 3.2 - Images of droplet formation in microfluidic system as function of 
aqueous flow rate (Qaqueous): (A) 0.22 - 0.47 μL min
−1 with small droplets, (B) 0.50 
μL min−1 forms ideal droplets, (C) 0.53 - 1.33 μL min−1  forms plugs and (C) above 
2.00 μL min−1 produces parallel flow streams. The drop size (λ), ratio of the droplet 
size to the serpentine channel width, varies from λ = 0.82 (A), 1.31 (B) until 2.10 
(C). The assays were developed with fixed Ca = 3x10-3, Qoil = 2 μL min
−1 and lipids 
from cationic liposomes at 2mM.  
3.2. Physico-Chemical properties of Cationic Liposome after droplet-based 
microfluidic processing 
The CL are formed by the self-assembly of two zwitterionic phospholipids, 
EPC and DOPE, and only one monocationic lipid, DOTAP. Since these lipids are 
amphiphilic molecules, one possibility is the interaction between the surfactant 
from the oil phase with liposomes, disrupting membranes or modifying the physico-
chemical properties, compromising lipoplex and transfection applications. To 
monitor possible changes in CL properties due to interaction between CL and Pico-
Surf 1surfactant, we measured the physico-chemical properties of CL before and 
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after being processed in the droplet system, as shown in Figure 3.3. In order to 
access CL properties after droplet-microfluidic processing, CL were injected at 0.67 
μL min−1 into the droplet-based microfluidic system (Figure 3.1B, serpentine-TC 
with split region), while the FC-40/Pico-Surf 1 was injected at 2 μL min−1 (device 
and flow rates similar to those used by Lee and Hsieh (29)). At the end, aqueous 
phase was recovered from w/o emulsion and characterized in terms of size, 
polydispersity and zeta potential. The size of cationic liposome before (95.54 ± 
15.38 nm) and after (86.85 ± 13.52 nm) droplet processing, the polydispersity 
index before (0.144 ± 0.016) and after (0.164 ± 0.022) and the zeta potential (60.50 
± 3.36 mV before and 57.60 ± 2.57 mV after) were similar (Supplementary data, 
Table S.1). Additionally, Figure 3.3 shows more clearly that there was no variation 
in liposome size distribution before and after processing in the droplet-based 
microfluidic device.  
 
Figure 3.3 - Number-weighted size distribution (diameter) of cationic liposomes 
before (solid line) and after (dashed line) being inserted in droplet-based 
microfluidic system. Each solid and dashed line represent mean of triplicate from 
independent experiments.  
Furthermore, following similar procedure, we replaced cationic liposomes by 
water as aqueous solution in order to verify a possible formation of surfactant 
micelles in the system. We verified the presence of colloidal structures close to 30 
nm in the water (data not shown) via dynamic light scattering. Thus, indicating that 
part of surfactant remained in the aqueous phase as micelles and it may be 
inserted in liposomes. However, observing results obtained with cationic liposomes 
(Figure 3.3), we confirmed that this residual surfactant was not appreciable to 
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change physico-chemical characteristics of the liposomes. In addition, oil FC-40 
and perfluoro-derived surfactants, like Pico-Surf 1, are biocompatible (30), so it is 
expected that the residual surfactant will not affect biological application of 
lipoplexes.  
3.3. Lipoplexes Synthesis: Influence of Molar Charge Ratio (R+/-) and Microchip 
Design  
The mainly factors that govern lipoplexes formation are cationic lipid/DNA 
charge ratio that affects the complexation kinetics (31) and the time and speed of 
mixing that influence the complex size distributions (32). Thus, we investigated the 
effect of molar charge ratio (ratio between cationic lipids from liposomes and 
nucleic acids) and microdevice design on the final physico-chemical properties of 
lipoplexes (Figure 3.4 and Supplementary data, Table S.2). First of all, we studied 
the operational parameter capillary number. For this, we used the microchip with 
serpentine-TC and split region (Figure 3.1B), fixed the R+/- at 3, the volume fraction 
at 0.25 and the capillary number ranged from 8x10-4 to 5x10-3 by varying the 
average flow velocity of the system (Supplementary data, Figure S.1). There was 
no tendency in lipoplexes properties according to Ca. Thus, we fixed the 
operational parameters volume fraction at 0.25 and capillary number at 3x10
-3 
(average flow velocity 6x10-3 m s-1) for further steps investigation. 
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          A      
 
         B  
  
Figure 3.4 – Impact of experimental parameters R+/- (A) and microchip design (B) 
on lipoplexes characteristics in terms of average diameter (number mean), 
polydispersity (PdI) and zeta potential. Volume fraction was set at 0.25 and 
capillary number at 3x10-3. The droplet-based microfluidic system with serpentine-
TC and split region (Figure 3.1B) was used to investigate R+/- varying of 1.5, 3, 5, 7 
and 10. For microchip design evaluation, R+/- was fixed at 3.0 and tested droplet-
based platforms with serpentine region (thin-TC and wide-WC channels) and in the 
presence or absence of split region (Figure 3.1B). The error bars represent 
standard deviation of means (n = 3). Means statistically significant different by 
Tukey’s test (P<0.10) were flagged with an asterisk (*). 
The influence of droplet system method in lipoplex formation was studied by 
varying R+/- of 1.5, 3, 5, 7 and 10 in microchip serpentine-TC with split region 
(Figure 3.4A). Surprisingly, all lipoplexes produced showed monodisperse 
population around 100 nm and PdI 0.2 and zeta potential around 40 mV. 
Conventional lipoplex preparation by hand shaking or vortexing usually provides 
the large size distribution of lipoplexes with increasing amount of DNA added 
(31,33). Balbino et al. (34) investigated microfluidic synthesis of 
EPC/DOTAP/DOPE lipoplexes in only aqueous phase. The authors showed similar 
profiles of lipoplexes at the same R+/- range studied, with exception of R+/- 1.5 (with 
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more quantity of pDNA). In this R+/- they found lipoplexes, with negative charge, 
polydispersity 0.5 and size about 500 nm. As a result, the droplet microfluidic 
system presented in this work can load more amount of pDNA in CL while 
maintaining lipoplexes monodisperse and with positive charge, characteristics 
specially required for some therapeutic vaccines (35).  Moreover, in vitro studies 
demonstrated that nanoparticles of size between 100 and 200 nm and 
polydispersity less than 0.2 (homogeneous size distribution) are more easily 
internalized by mammalian cells, assuming that they would expend less energy in 
their capture (36,37). Cells usually have a negative surface charge, thus lipoplexes 
with positive charge were easier internalized (3), besides indicating storage 
stability of complexes over time. Therefore, it was expected that all lipoplexes 
investigated would be able to transfect dendritic cells. Moreover, the differences 
obtained from Balbino et al. (34) and this current work strongly suggest the 
superiority of droplet microfluidic systems in generate lipoplexes with high DNA 
loading, keeping the physico-chemical properties close to proper characteristics for 
transfection.  
Then, we investigated the influence of residence time and droplet mixing in 
complex properties by using different microdevice designs in lipoplexes formation 
(Figure 3.1B). For a given average flow velocity (U), the residence time of the liquid 
is increased by increasing the length of the channel so as to ensure complete 
mixing (39). In this work, we changed the residence time by modifying serpentine 
channel length and also the mixing by modifying serpentine channel width. The 
serpentine channel width interfere in the chaotic mixing inside droplets due to the 
fluid movement relative to the stationary walls (13). In some designs the mixing 
channel is branched into multiple narrower channels (split region) to ensure mixing 
in a shorter residence time (38). Thus, we used four different droplet-based 
microfluidic systems (Figure 3.1B), two types of serpentine widths (TC-200 μm and 
WC-400 μm) and in the presence or absence of split mixing region, to obtain 
lipoplexes with R+/- 3. Thus, the microchip with wide serpentine channel had the 
linear length 2 times the thin channel, leading to a residence time in WC (3.2 s) 2 
times greater than in TC (1.6 s), for a constant flow velocity (U = 6x10-3 m s-1). 
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Droplet-based microfluidic systems with thin and wide serpentine channels 
presented Re values of 1.3x10-4 and 1.2x10-4, respectively. The mixing contribution 
in this Re range is not dramatic (20).  
We can observe in Figure 3.4B that lipoplexes produced in all microchips 
presented average diameter next to 200 nm and PdI 0.2, exception of microfluidic 
system with wide serpentine channel without split region that showed higher PdI 
(0.392 ± 0.013). In this case, the use of serpentine-WC/without split presented 
negative influence on PdI index, suggesting poor mixture. The residence time in 
serpentine-WC/without split greater than in serpentine-TC/without split was not 
sufficient to decrease the lipoplexes PdI. However, the higher PdI value obtained in 
the serpentine-WC/without split is overcome with the addition of split region, 
favoring mixture. The serpentine-TC/without split showed that the mixing provided 
by the split region (10) it is not mandatory to control lipoplex PdI, since only 
generation of small droplets due to the constriction of serpentine channel width 
already lead to this result. Handique and Burns (39) modeled the mixing of solutes 
present in a drop moving in a slit-type microchannel. They showed that shorter 
plugs will mix in a shorter distance and therefore in a shorter time, considering a 
constant average flow velocity. Thus, to complex CL with pDNA the most important 
parameter in this droplet-microfluidic system is the mixing generated in the thin 
serpentine channel. Rakhmanov et al. (32) compared different methods of 
lipoplexes production, a slow preparation by magnetically stirred and a quick 
preparation by pipette shaking. As a result, for the low concentrated solutions, the 
most monodisperse lipoplex population was formed by magnetically stirred 
method, showing the relevance of a controlled mixing. Moreover, zeta potential of 
lipoplexes remained around 40 mV, independent of microdevice design used 
(Figure 3.4B). The choice between microchip with thin or wide serpentine channel 
should not be only related to the mixing provided by them, but also the ease of 
system handling. Wide serpentine channel is easier and faster to operate than thin 
channel, because of the higher flow used and less chance of clogging. Additionally, 
the connection of a split region to this serpentine-WC channel improves mixing 
inside droplets. Thus, we decided to use the droplet-based microfluidic systems 
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with wide serpentine channel and split region to produce lipoplexes for DCs 
transfection. 
3.4. Biological Evaluation of Lipoplexes to Transfect DCs  
Lipoplexes produced in the chosen microfluidic system parameters, droplet-
based microfluidic system with serpentine-WC with split region operating at fixed 
volume fraction 0.25, capillary number at 3x10
-3 and R+/- varying in 1.5, 3, 5, 7 and 
10, were evaluated in their capacity to transfect DCs. For this, at first, lipoplexes 
were characterized in terms of average diameter, PdI and zeta potential as shown 
in Figure 3.5.  
   A                                           B                                             C 
      
Figure 3.5  – Physico-chemical properties of lipoplexes produced in microfluidic 
system in terms of average diameter (number mean) (A), polydispersity (PdI) (B) 
and zeta potential (C). The droplet-based microfluidic system with wide serpentine 
channel (WC) and split region was operated with volume fraction 0.25, Ca = 3x10-3, 
Qoil = 6.5 μL min
−1 and R+/- varying in 1.5, 3, 5, 7 and 10. The error bars represent 
standard deviation of means (n = 4). Means statistically significant different by 
Tukey’s test (P<0.10) were flagged with an asterisk (*) and non-different means 
with “ns”. 
Similarly as lipoplexes synthesized in microchip with serpentine-TC with split 
region (Figure 3.1B), lipoplexes obtained in the chosen conditions (Figure 3.5) 
showed size around 100 nm and PdI 0.20. However, lipoplexes R+/- 5 and 7 
obtained in chosen conditions (Figure 3.5B) showed higher PdI (0.30 ± 0.03 and 
0.35 ± 0.10, respectively). This is probably due to irregular motion of the syringe 
pumps that induced fluctuations  in  relative  flow  rates (26); reflecting in the 
mixing for lipoplex formation kinetics. Charge of lipoplexes decreased from 40 mV 
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in thin serpentine channel (Figure 3.4B) to 30 mV when synthesized in wide 
channel (Figure 3.5C). The better mixing provided by thin channel lead a lower 
reduction in liposome charge with pDNA addition, than in wide channel. After 
characterized, these lipoplexes synthesized in microchip serpentine-WC with split 
were evaluated in terms of efficacy to transfect (TE) dendritic cells in vitro by 
analyzing cell GFP production (Figure 3.6).   
 
Figure 3.6 - In vitro transfection efficacy (TE) of dendritic cells using lipoplexes at 
different molar charge ratios (R+/- 1.5, 3, 5, 7 and 10) synthesized by microfluidics 
method. The droplet-based microfluidic system with wide serpentine channel (WC) 
and split region was operated with volume fraction 0.25, Ca = 3x10-3, Qoil = 6.5 μL 
min−1 and R+/- varying in 1.5, 3, 5, 7 and 10. The error bars represent standard 
deviation of means (n = 4). Means statistically significant different by Tukey’s test 
(P<0.10) were flagged with an asterisk (*).  
DCs showed higher transfection efficiency when using lipoplexes R+/- 10 
produced by microfluidic method (4.44 ± 0.35%) (Figure 3.6). The low transfection 
efficiency of DCs via lipofection is already known. VAN TENDELOO et al. (5) 
transfected monocyte-derived DCs with mRNA encoding GFP by lipofection 
achieving 4% of TE. DCs use phagocytosis and/or macropyocytosis as effective 
pathway for transfection (9), which requires more precise lipoplex size and PdI to 
transfect (42). Besides the statically analysis, lipoplexes R+/- 10 showed tendency 
to lower size (85.27 nm) and PdI (0.20) than the others. Moreover, transfected DC 
with lipoplexes containing less nucleic acid (R+/- 10) can be advantageous, since 
DCs exposed to high concentration of nucleic acids can significantly express less 
cytokines and activation markers (43).  
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 Besides transfecting, lipoplexes should activate DCs in order to allow 
antigen presenting cells to play their role as immunological response starter. For 
this, the increase of costimulatory molecules expression by dendritic cells was 
evaluated for lipoplexes synthetized by microfluidic method. Figure 3.7 showed DC 
expression of CD80 and CD86 when treated with lipoplexes R+/- 1.5, 3, 5, 7 and 10. 
         A 
 
        B 
        C 
 
Figure 3.7 - DCs activation after transfection with lipoplexes produced by 
microfluidics method. The droplet-based microfluidic system with wide serpentine 
channel (WC) and split region was operated with volume fraction 0.25, Ca = 3x10-3, 
Qoil = 6.5 μL min
−1 and R+/- varying in 1.5, 3, 5, 7 and 10. Histograms of CD80 (A) 
and CD86 (B) (costimulatory molecules B7-1 and B7-2, respectively) expressed by 
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DCs is shown. Histograms of DC granulocyte (SSC – side scatter) (C) indicate 
lipoplex internalization by cells. Histograms are composed of iDC (immature 
dendritic cells) represented by solid dark lines overlaid by histogram of DCs treated 
with corresponding type of lipoplex represented by solid-filled background. 
 The median fluorescence intensity (MFI) of CD80 expressed by DCs 
transfected with lipoplexes R+/- 1.5 (MFI = 5.73), 3 (11.00), 5 (11.10), 7 (10.60) and 
10 (8.74) increased in relation to iDC (3.92), as shown by Figure 3.7A shifting the 
corresponding curve to right. In a similar way, the MFI of CD86 expression 
increased for all lipoplexes R+/- 1.5 (10.30), 3 (15.40), 5 (15.10), 7 (13.70) and 10 
(11.00) regarding to iDC (8.74) (Figure 3.7B). The positive control (mDC – mature 
dendritc cells) also increased the MFI of CD80 (4.49) and CD86 (9.56) expression. 
Beyond that, we verified, such as in previously studies (7,8), that empty cationic 
liposomes EPC/DOTAP/DOPE activated DCs (MFI of CD80 increased to 7.23 and 
for CD86 to 12.20). The lipofection action upon DCs activation was also showed by 
Denis-Mize et al. (42) by co-culturing transfected DCs via cationic microparticles 
with antigen-specific T cells. They verified an increase in IL-2 production by the 
culture in function of microparticle tested.  
Another parameter evaluate was the variation in DC granularity (SSC) 
according to lipoplexes used (Figure 3.7C). DCs showed to increase granularity 
(internal structure and complexity) when incorporating this cationic liposomes (7). 
Thus, median of SSC of DCs increased when transfected with all lipoplexes tested 
R+/- 1.5 (median of SSC = 258), 3 (410), 5 (415), 7 (422) and 10 (399) comparing 
to iDC (248) and mDC (217). Even though easier uptake by DCs, lipoplex R+/- 7 did 
not present the best TE since there is a specific pathway that lipoplexes should be 
internalized to effectively produce the recombinant protein (9).  
4. Conclusion 
The droplet-based microfluidic system was used to produce lipoplexes in 
reproducible and suitable strategy to transfect DCs. Droplet system operating at 
volume fraction, ratio between Qaqueous and Qoil, 0.25 ensure the droplet formation 
with size 1.5 times the serpentine channel. Cationic liposomes maintain their 
properties after processing, even if surfactant residual in the aqueous phase. Thus, 
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allowing the use of these cationic liposomes in other droplet devices. This droplet 
microfluidic system allow the incorporation of more amount of pDNA to CL (R+/- 
=1.5) than conventional method, while maintaining lipoplexes monodisperse and 
with positive charge. Mixing provided by droplets formed in thin serpentine channel 
(200 µm of width) lead to decrease lipoplexes polydispersity. Lipoplexes R+/- 10, 
exhibiting lower size and PdI tendency, provided the higher transfection efficiency 
in DCs, besides activating them. Therefore the droplet-based microfluidic system 
showed as a potential tool to modulate lipoplexes properties on demand.  
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7. Supplementary data 
7.1. Physico-Chemical properties of Cationic Liposome Stability after droplet-
based microfluidic processing 
Investigation of cationic liposomes stability in w/o emulsion by measuring 
physico-chemical properties of cationic liposomes before and after processing in 
droplet-based microfluidic device (Table S.1).  
Table S.1 - Physico-chemical properties of cationic liposomes before and after 
droplet-based microfluidic processing.  
Results represent means ± S.D., n = 3.  
(i) Number-weighted average diameter and distribution (N-distribution).  
(ii)PdI: Polydispersity index of samples vary in ascending order from 0 to 1. 
7.2. Investigation of experimental parameters: Capillary Number (Ca), Molar 
Charge Ratio (R+/-) and Microchip Design  
The effect of capillary number in lipoplexes physico-chemical properties was 
showed in Figure S.1. Comparing physico-chemical characteristics of lipoplexes 
formed in Ca ranging from 8x10-4 to 5x10-3 (Figure S.1), there was no difference in 
lipoplexes size around 100 nm, even the high standard deviation (144.03 ± 52.16 
nm) presented by lipoplexes produced at Ca 1x10-3. In general, lipoplexes 
polydispersity remained about 0.2, exception of lipoplexes obtained at Ca 1x10 -3 
that presented higher polydispersity (0.467 ± 0.005). Moreover, considering zeta 
potential analysis, lipoplexes had a positive charge around 45 mV, even with pDNA 
Cationic 
liposomes 
Mean diameter (± S.D.) nm 
and distribution (± S.D.) %(i) 
Pdl(ii) 
Zeta potential  
(± S.D.) mV 
Before droplet 
processing 
95.54 ± 15.38 (100 ± 0) 0.144 ± 0.016 60.50 ± 3.36 
After droplet 
processing 
86.85 ± 13.52 (100 ± 0) 0.164 ± 0.022 57.60 ± 2.57 
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addiction in cationic liposomes. However, when produced at Ca 1x10-4 and 1x10-3, 
their charge decreased achieving 25.03 ± 6.64 mV and 30.87 ± 4.10 mV, 
respectively.  
 A                                          B                                          C 
 
Figure S.1 – Impact of capillary number (Ca) on lipoplexes characteristics in terms 
of size (A), polydispersity (PdI) (B) and zeta potential (C). The droplet-based 
microfluidic system with serpentine-TC and split region (Figure 3.1B) was set at 
volume fraction 0.25, R+/- = 3 and varying Ca from 8x10
-4 to 5x10-3. The error bars 
represent standard deviation of means (n = 3). Means statistically significant 
different by Tukey’s test (P<0.10) were flagged with an asterisk (*) and non-
different means with “ns”. 
 
Then, the effect of molar charge ratio and different microdevice designs on 
the final physico-chemical properties of lipoplexes synthesized in droplet-based 
microfluidic devices (Table S.2). 
Table S.2 - The effect of molar charge ratio (R+/-) and microchip design on physico-
chemical properties of lipoplexes.  
 Variable 
parameter 
Mean diameter (± S.D.) nm and 
distribution (± S.D.) %(iii) 
Pdl(iv) 
Zeta potential 
(± S.D.) mV 
R
+
/-
(i
)  
1.5 176.95 ± 35.71 (100.0 ± 0) 0.292 ± 0.152 39.50 ± 8.51 
3.0 161.10 ± 15.98 (100.0 ± 0) 0.202 ± 0.029 38.83 ± 9.42 
5.0 158.45 ± 14.50 (100.0 ± 0) 0.281 ± 0.111 51.73 ± 7.91 
7.0 138.05 ± 2.48 (100.0 ± 0) 0.217 ± 0.069 44.10 ± 6.32 
10.0 151.75 ± 2.05 (100.0 ± 0) 0.185 ± 0.057 49.73 ± 10.30 
D
e
s
ig
n
(i
i)
 
TC without 
split 
249.35 ± 3.23 (56.2 ± 7.92) 
107.34 ± 17.62 (43.8 ± 7.92) 
0.235 ± 0.057 41.50 ± 7.64 
TC with split 159.80 ± 17.82 (100.0 ± 0) 0.189 ± 0.024 44.20 ± 2.12 
WC without 
split 
249.4 ± 7.57 (58.3 ± 7.5) 
99.58 ± 12.76 (41.7 ± 7.5) 
0.392 ± 0.013 27.90 ± 1.41 
WC with split 159.07 ± 13.06 (100.0 ± 0) 0.240 ± 0.016 36.80 ± 14.40 
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At first, the droplet-based microfluidic system with serpentine-TC with split regions 
(Figure 3.1B) operated with volume fraction set at 0.25 and Ca at 3x10-3, R+/- 
varied of 1.5, 3, 5, 7 and 10. Then, to evaluate microchip design, volume fraction 
was set at 0.25, Ca at 3x10-3 and R+/- at 3.0. Droplet-based platform with thin (TC) 
and wide serpentine channel (WC) and with or without a split region (Figure 3.1B) 
were tested. Results represent means ± S.D., n = 3.  
 (i)R+/-: molar charge ratio between nucleic acids and cationic lipids from liposomes. 
(ii)Device design: Droplet-based microfluidic system with two types of serpentine 
widths (TC-200 μm and WC-400 μm) and in the presence or absence of split 
region (Figure 3.1B). 
(iii)Intensity-weighted average diameter and distribution (I-distribution). 
(iv)PdI: Polydispersity index of samples vary in ascending order from 0 to 1. 
7.3. Strategy of dendritic cells and GFP analysis 
For phenotypic characterization and evaluation of the liposomes 
incorporation, we delimited gate with cell size and granularity compatible with the 
DCs, by analysis of the "side scatter" (SSC) - granularity (internal structure and 
complexity) and the "forward scatter" (FSC) - relative size of the cells (Figure 
S.2A). Considering the analyzed region bounded by the gate, cells were analyzed 
through the expression of the myeloid marker CD11c and the antigen presenting 
cell marker, HLA-DR. Furthermore, when we analyzed the expression of co-
stimulatory molecules, CD80 and CD86, within the population HLA-DR+CD11c+, 
called Gate R1 (Figure S.2B) in order to investigate DC activation.  
 
Figure S.2 – Strategy of dendritic cells analysis. (A) Dot Plot graph of SSC (side 
scatter) by FSC (forward scatter) to delimit DCs gate. (B) Graph of CD11c versus 
HLA-DR to delimit Gate R1, corresponding to cells double-positive.  
A B 
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Then, to determinate the transfection efficiency, we used FITC histograms of 
DCs treated with liposomes and lipoplexes, like showed in Figure S.3, in order to 
detect the GFP production and, consequently, the ratio between GFP producer 
cells and total of DCs in Gate R1. For this, we plotted FITC histogram of DCs in 
Gate R1 treated with liposomes (filled graph with solid line in Figure S.3) to define 
the gate of negative FITC that is around 99% of this population. Then, we overlaid 
the graph with the FITC histogram of DCs in Gate R1 treated with lipoplexes 
(empty graph with dot line in Figure S.3) to define the TE provided by the 
lipoplexes analyzed.  
 
 
Figure S.3 – Strategy of transfection efficiency analysis. At first, we determined the 
negative gate of FITC that is around 99% of this population in the FITC histogram 
of DCs from Gate R1 treated with liposomes (filled graph with solid line). Then, we 
overlaid the graph with the FITC histogram of DCs from Gate R1 treated with 
lipoplexes (empty graph with dot line) in order to define the TE provided by the 
lipoplexes analyzed.  
The procedure to define Gate R1 was performed for all samples, such as 
mature dendritic cells stimulated by TNF-α (positive control - mDC), immature 
dendritic cells (iDC), DCs treated with liposomes and lipoplexes. In case of 
transfection efficiency, the strategy showed below was applied for all DCs in Gate 
R1 treated with liposome and lipoplexes.  
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Abstract  
Transient gene expression technology (TGE) enables the rapid production of 
large amount of recombinant proteins, without the need of fastidious screening of 
the producing cells required in conventional protocols using stable transfection 
(ST). However, several barriers require to be overcome before reaching the 
production yield achievable by ST. In view of optimizing the production yields in 
TGE, a better understanding and control over the transfection conditions at single 
cell level using are critically required. In this study, a universal droplet microfluidic 
platform was used to assess the heterogeneities of CHO-S population transiently 
transfected with different types of lipoplexes. A single cell analysis of GFP 
production kinetics revealed the presence of a subpopulation producing 
significantly high levels of recombinant proteins. The charge and the DNA content 
of the different lipoplexes regulated differentially HPs average size, their relative 
abundance and their specific productivity. These high producers showed increased 
cell size in comparison to the average population. Lipoplexes with positive charge 
produced more HPs. Lipoplexes loading more amount of pDNA showed the higher 
GFP specific productivity of HPs.  
 
Keywords: droplet microfluidics, transient gene expression, cationic liposomes, 
single-cell analysis. 
1. Introduction 
In the past decades, Chinese Ovary cells (CHO) have emerged as one of the 
most powerful tool for the production of recombinant therapeutic proteins. CHO 
cells can secrete very high recombinant product yields, which glycosilation profile 
promotes their efficient bioactivity. Moreover, CHO cells have been successfully 
adapted for expansion in serum free media and for large-scale culture in stirred 
tank bioreactors (1,2). Consequently, current bioprocess making use of CHO cells 
can effectively meet the clinical demand (3).  
The first step to achieve the production of recombinant proteins by CHO cells 
requires their genetic engineering. While CHO cells can be easily transfected, 
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current protocols require transgene integration in the host genome, which usually 
followed by lengthy procedure of clonal selection and adaption to large-scale and 
animal protein free culture conditions (3). Contrasting with these labor-intensive 
procedures of stable transfection (ST), transient gene expression technology 
(TGE) enables the rapid production of large amount of recombinant, without the 
need of fastidious screening of the producing cells. Moreover, no adaption to new 
culture condition is required (4). However, several barriers require to be overcome 
before reaching the production yield achievable by ST. Among them, because of 
the episomal location of transgene, exogenous DNA is lost after several rounds of 
cell division. As a consequence, the production occurs for significantly shorter time 
period than ST. In addition, the limited control over DNA delivery induces a large 
heterogeneity in the production rate of individual cells (5). Consequently, in view of 
optimizing the production yields, a better understanding and control over the 
transfection conditions at single cell level using TGE are critically required. 
Several carrier systems, such as viral and nonviral vectors, are currently used 
for the delivery of recombinant nucleic acids into producing cells (6). While nonviral 
systems complexed with nucleic acids (e.g. lipoplexes and polyplexes) show 
significantly lower transfection efficiency, they demonstrate biological inertness, 
improved safety and they can be easily produced at large-scale, in contrast to viral 
systems. Consequently, current research efforts are directed to increase the 
efficiency of nonviral vectors for DNA delivery, by better understanding the 
mechanism of lipoplex uptake and internalization (7).  
On other hand, the recent advances in microfluidics have created exciting 
prospects for gene delivery and therapy. The controlled hydrodynamics within 
microfluidic systems enables precise control of parameters involved in gene 
transfection, together with a significant reduction of the volumes of reagents (8). 
More recently, droplets microfluidics has enabled the development of new tools for 
cell manipulation, such as the encapsulation of individual cells, the biological 
compartmentalization etc (9,10). More importantly, the rapid accumulation of 
secreted protein in droplets enables their detection within shorter time period than 
conventional culture systems (e.g. culture flask, bioreactors etc.). In addition, 
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single-cells in droplets can be monitored for long time periods, which enables to 
dynamically track individualized response to biological stimuli by optical imaging 
(11). However, while investigations demonstrated the capability of such devices to 
support non-viral transfection (12), the full capability droplets to support the long 
term tracking and, consequently, to better understand the cell production 
heterogeneity after TGE has not been exploited so far. 
Thus, this work aims at deeply investigating the response of a CHO-S 
(recombinant CHO cells suspension culture) population under different transient 
transfection conditions. For this purpose, the applications a droplets microfluidic 
platform will be extended to investigate, at the single cell level, the influence of 
different types of lipoplexes on production of recombinant GFP.  
2. Materials and methods 
2.1. Microfabrication 
Standard dry soft lithography was used for the fabrication of the single-cell 
microchip and the liposome production device, as previously described (13). 
Briefly, dry film photoresists (Eternal Laminar, Taiwan) were sequentially laminated 
with an office laminator (PEAK PS320, UK) at 100°C on a glass slide, then 
exposed to UV light (LightningCure LC8, Hamamatsu, Japan) with the photo-
masks. The molds were revealed using a 1% w/w K2CO3 (Sigma-Aldrich, USA). 
Polydimethylsiloxane (PDMS, Dow-Corning Sylgard 184, USA, 1/10 ratio of curing 
agent to bulk material) was poured on mold and cured 2 h at 70 °C. The replicate 
was covalently bonded to a glass slide using a plasma cleaner (Harrick, Ithaca, 
USA). In order to provide the manipulation of aqueous droplets in oil, the chips 
were filled 3 times with Novec Surface Modifer (3M, Paris, France), for 30 minutes 
at 110°C on a hot plate. In case of chip for liposome production, this surface 
treatment was not necessary.   
The microchip design consists in a 2D chamber with two inlets and one outlet 
(Figure 4.1A). Single-cell droplets were trapped in 1495 square anchors of             
d = 120 μm of side, spaced by δ = 240 μm (Figure 4.1A). The chamber has h1 = 35 
μm of height and the anchors h = 135 μm (Figure 4.1B). Cationic liposomes (CL) 
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were produced in a single hydrodynamic focusing microfluidic device like Balbino 
et al. (2013). The cross-junction design has a rectangular cross-section of depth 
100 μm and height 135 μm.  
 
Figure 4.1 - Design of microchip where CHO-S cells were cultivated. The microchip 
dimension is 0.5 × 4.8 cm with 1495 square anchors (115 × 13). The microchip 
have two inlets: 1 for oil phase (FC-40/RAN) and 2 for aqueous phase (cells + 
lipoplexes + agarose), and one exit (3). Microchip top view (A) shows that each 
square anchor has d = 120 μm of side, spaced by δ = 240 μm. Lateral section (B) 
shows that the chamber height is h1 = 35 μm and the anchor height h = 135 μm.  
2.2. Production and Characterization of CL and their Complexes 
Cationic liposomes were formed along the main channel of cross-junction 
microfluidic device. At first, EGG (egg phosphatidylcholine), DOTAP (1,2-dioleoyl-
3-trimethylammonium-propane) and DOPE (1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine) (50/25/25 % molar) all from Lipoid (Germany) were 
dispersed in anhydrous ethanol to achieve 25 mM of total lipid concentration, 
following the protocol established by Rigoletto et al. (15). The lipid dispersion was 
injected into the center flow at 10.92 μL min−1. Simultaneously, DEPC-treated water 
(Life Technologies, USA) were injected at 54.6 μL min−1 into two lateral sides. 
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Liposome samples were collected from the exit and leaved for at least 4 hours at   
4 °C. 
 For lipoplexes formation, the CL and pDNA (pMAX GFP, Lonza – see Annex 
I) were mixed by vortexing for 30 seconds. Several liposomes/pMAX GFP molar 
ratios were used to produce different types of lipoplexes, characterized by R+/-, the 
ratio between the positive charge from cationic liposomes and negative charge 
from pDNA. Cells were transfected setting pDNA at 0.07 µg and liposomes varying 
from 1.77 µL (R+/- = 5), 1.05 µL (R+/- = 3) and 0.53 µL (R+/- = 1.5).    
To characterize the nanoparticles properties, CL and their lipoplexes were 
diluted in DEPC water. The average hydrodynamic diameter, the size distribution, 
polydispersity index and zeta potential were measured by dynamic light scattering 
(the scattering angle was 173°, backscattering) (Malvern Zetasizer Nano Series, 
model ZEN3600 - UK) using a Ne–He laser. The mean diameter and the 
distribution of particle sizes were calculated using CONTIN algorithm. 
2.3. Cell Culture and Labeling 
FreeStyle CHO-S (Life Technologies, CA, USA) cells were cultivated at 37°C 
into 25 cm2 Ultra-Low Attachment flasks (Corning, USA) in a humidified incubation 
set up at 8% CO2. The culture medium was composed of FreeStyle CHO 
Expression Medium supplemented with 8 mM GlutaMAX (Gibco, USA). The cells 
were passaged every 48–72 hours, by reseeding at a concentration of 1 x 105 
cells.mL−1. 
To monitor the CHO-S behavior in culture, the cells were labeled with 
CellTracker Red CMTPX Dye (Thermo Scientific), following the manufacturer 
instructions. To measure the viability, the CHO-S were stained for ReadyProbes 
Cell Viability Imaging Kit Blue/Red (Thermo Scientific), according to the provided 
directions. 
2.4. Gels 
Type IX ultra-low-gelling Agarose (Sigma) was used to provide a mechanical 
support for the non-adherence cells to keep them stationary. The EEO 
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(electroendosmosis) of this specific type of agarose is low (i.e. <0.12), ensuring 
limited electrostatic interactions (either attractive or repulsive) between charged 
lipoplexes and the hydrogel. The average pore size of the agarose gels is of about 
500 nm, thus significantly larger than the lipoplexes size. For the experiments, a 70 
L solution containing 5 x 103 cells in culture medium was mixed with a 0.3% liquid 
agarose solution. The concentration of resulting agarose gels was of about 1%. At 
this concentration, the mechanical properties of the agarose gel enable the cells to 
be firmly retained in the anchors (16). However, it was expected to observe a 
limited cell growth of the agarose encapsulated CHO-S, due to the low metastatic 
potential and the low degree of transformation of CHO-S at low passage number 
(17).  
2.5. Chip Loading and In-Situ Transfection 
The chip loading with cells was performed using a three-step protocol, as 
previously described (16).  (1) The microchip is entirely filled with FC-40 (Fluorinert 
Electronic Liquid FC-40 from 3M, USA), a fluorinated oil, supplemented with 0.5% 
(w/v) a PEGylated surfactant (008-FluoroSurfactant, RAN Biotechnologies, USA); 
(2) the FC-40/surfactant flow is stopped and a solution containing 5 x 103 cells (70 
µL), 3 % w/v ultra-low gelling agarose (Sigma) (30 µL) and 4 µL of lipoplexes at 
different molar charge ratio (R+/- = 1.5, 3 and 5) in culture medium is flowed at 10 
µL min-1, we used 10-5 µg pDNA/cell and aprox. 105 lipoplexes (number of 
particles)/cell for all conditions (see supplementary data);  (3) once the chamber is 
filled the flow of cells/lipoplexes solution is stopped and FC-40/RAN inserted at a 
flow rate increasing from 5 to 50 µL min-1 to push the cells/lipoplexes solution 
towards the exit. This creates droplets containing the cells and the lipoplexes 
sample immobilized on each anchor (18). To promote the interaction between the 
cells and lipoplexes, the chip was placed for 1 hour in the CO2 incubator. After 
incubation, the chip was flushed with pure FC-40 at 20 µL min-1 to wash surfactant 
and the agarose was gelled by placing the chip at 4 °C for 15 minutes. The 
solidification of the gel droplets allowed us to replace the oil with culture medium, 
which was flushed into the chip at 20 µL min-1 for 10 minutes in order to wash away 
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the remaining not internalized lipoplexes. Finally, the microchip was filled again 
with FC-40/surfactant, which surrounded the agarose spheres, thus isolating the 
droplets from each other. The GFP production was tracked by time lapse 
microscopy for 62 hours using a fluorescents microscope (Nikon Eclipse Ti-U, 
Japan), equipped with a EM-CCD (Andor Technology, Northern Ireland). 
2.6. Image and Data Analysis 
To track recombinant protein production, images were taken every two hours 
in bright field and in fluorescence to detect CellTracker Red (red filter) and GFP 
(green filter). Recombinant GFP production was measured by quantifying the 
green filter intensity evolution of each detected cell. A custom-made MATLAB 
R2015b program was used to process the images. First, the images with 
CellTracker Red signal in anchors were thresholded and converted into masks. 
The objects with a diameter comprised between 10 and 25 µm were considered as 
cells. The green signal intensity (Icell) was then quantified for each mask derived 
from the red labeled objects. The green signal measured in rest of the anchors was 
considered as the background (Iback). The green signal per cell (I) was defined as 
the value of the green signal in the mask minus the green signal in the background: 
I=Icell-Iback. In further calculations, it was useful to measure the variation in I 
between each time and the initial value (I0). For this we define I =I-I0. 
To measure cell viability, single cells were identified as above from the DAPI 
signal (i.e. NucBlue™ - stained cells). The cells in the DAPI masks labeled for 
Propidum Iodide were considered as dead cells.   
2.7. Statistical Analysis  
Each experiment was conducted at least two times. To assess the statistical 
significance between three independent samples, we used the Kruskal-Wallis test 
and, to compare two related samples, we used Wilcoxon rank sum test. A p-value 
< 0.05 was considered statistically significant for both tests. 
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3. Results and Discussion 
TGE enables the production of high recombinant protein yields, whithout the 
need of lenghty procedures of clonal selection. However, there have been few 
investigations on the contribution of individual cells on the rate of recombinant 
protein production of the global population. This work investigates the 
heterogeneities of GFP expression in a CHO-S population transfected with 
differents types of lipoplexes. The cationic liposomes EPC/DOTAP/DOPE were 
produced on a chip and then complex with recombinant DNA in various molar 
charge ratios (R+/-). Lipoplexes were characterized based on their diameter, PdI 
and ζ. Then, CHO-S were individualized and in situ transfected using a universal 
droplet microfluidic chip (16). 
3.1. Characterization of the Physico-Chemical Properties of Liposomes and 
Lipoplexes  
Cationic liposomes (EPC/DOTAP/DOPE) and lipoplexes (R+/- = 1.5, 3, 5) had 
their properties (size; polydispersity, PdI; and zeta potential, ζ) analyzed and 
compared by dynamic light scattering (Figure 4.2).  
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Figure 4.2 - Physico-chemical properties of CL (cationic liposomes 
EPC/DOTAP/DOPE) and their lipoplexes R+/- = 5, 3 and 1.5. (A) Size represented 
by intensity-weighted distribution disposed in a way to show the increase in ratio 
pDNA / liposomes when getting down, like represented by arrow in the right. The 
dotted, dashed and solid lines in each graph represent one independent size 
distribution. (B) Zeta potential was no significantly different (ns) between cationic 
liposome and lipoplexes R+/ 5, and between lipoplexes R+/- 3 and 1.5, but different 
among groups by Wilcoxon rank sum test at 5% significance level. Measures were 
done in the same conditions as nanoparticles were mixed with cells, i.e., CL and its 
lipoplexes was diluted in DEPC water. Results represent means ± S.D., n = 3.  
The CL average diameter was of 113.56 ± 1.49 nm. The diameter of the 
liposome population presented a monomodal distribution, as shown by a single 
peak around 110 nm (Figure 2A). The PdI of the CL was of 0.193 ± 0.013. We can 
observe that increasing the pDNA content into the liposomes (i.e. decreasing R+/- 
values from 5 to 1.5), the intensity-weighted size distribution tend to increase its 
heterogeneity. This tendency has already been discussed by Balbino et al. (2012), 
demonstrating that the number of double bilayers increases as pDNA content 
increases and specially for R+/- close to 1.8 it can be detected the presence of a 
fraction of aggregates with multiple bilayers.The lipoplex average size was    
108.03 ± 1.20, 106.57 ± 1.36 and 157.67 ± 9.69 nm, for  R+/- 5,  3 and 1.5, 
respectively. Besides the differences in heterogeneity, lipoplexes presented PdIs 
ranging from 0.15 to 0.21.   
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The electric charge of liposomes and the different lipoplexes was analyzed by 
measuring their zeta potential (ζ). The cationic liposomes EPC/DOTAP/DOPE 
presented cationic characteristic and showed similar ζ (i.e. 48.7 ± 13.92 mV) 
(Figure 2B). The net charge of R+/- 5 lipoplex was similar to the empty liposomes (ζ 
= 45.10 ± 3.57 mV). Surprisingly, the complexation with more pDNA significantly 
increased the electronegativity of R+/- 3 and 1.5 lipoplexes (i.e. - 15.80 ± 4.24 mV 
and - 15.40 ± 3.06 mV, respectively) (Figure 2B), since previous studies 
demonstrated that these lipoplexes presented positive zeta potential (19,20). The 
differences can be related to the conditions for liposome synthesis and pDNA 
complexation; this present work used DEPC-treated water as diluent while other 
studies with this liposome system used PBS (19) or sterile water for injection (20). 
3.2. Single CHO-S Cell Trapping and Transfection on Chip 
The chip consisted in a high aspect ratio chamber equipped with 1495 
anchors. The protocol began with the entire chip filling with oil phase FC-40/RAN, 
which was then replaced by an aqueous phase containing CHO-S cells, liquid 
agarose and culture medium. The capillary anchors provided high confinement 
areas for the aqueous phase, contrasting with its lower confinement in the culture 
chamber. The oil flow in the chamber containing the aqueous phase induced a 
Rayleigh-Plateau instability around the anchors, a local minima of the surface 
energy of the aqueous–oil interfaces (21). Consequently, the procedure yielded to 
the formation of 1495 monodispersed aqueous droplets of a 2 nL volume, trapped 
in the anchors (Figure 4.3A). After trapping, the distribution of CHO-S cells inside 
the anchors follows a Poisson law (i.e. 33% of the anchors contained only one cell) 
(Figure 4.3B). In the following part of this study, only the anchors containing single 
CHO-S cell will be considered for the analysis. As the CHO-S cells were 
encapsulated in agarose, its gelation enabled to mechanically retain the cells in the 
anchors and to perform several rounds of phase change (i.e. oil-to-medium and 
medium-to-oil). This phase change was necessary to avoid cell nutrition depletion 
and toxic metabolites. Thus, the protocol resulted in the isolation of single CHO-S 
cells and it enabled long-term culture (at least up to 62h) with an individual cell 
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tracking. By the end to the culture period, the isolated single CHO-S remains highly 
viable on-chip (81.09 ± 13.39%), just as usually cells cultivated in conventional well 
plates (Figure 4.3C).  
Next, the platform was applied for studying the CHO-S productivity in GFP by 
transient transfection using the different types of lipoplexes. For this purpose, the 
aqueous phase containing CHO-S cells, liquid agarose and culture medium was 
supplemented with the CL complexed with pMAX-GFP. CHO-S cells were 
incubated with lipoplexes for 4 hours in the anchors to interact with pDNA. Then, 
phase change was performed to wash the excess of lipoplexes from the microchip. 
The potential toxicity of the lipoplexes was examined by Live/Dead staining and the 
production of GFP was kinetically monitored by time lapse, immediately after the 
washing of the excess of lipoplexes. Figure 4.3C demonstrated that CHO-S 
retained high viability after transfection and long-term culture, whatever the type of 
lipoplexes (74.69 ± 35.90% for R+/- 5, 70.78 ± 25.52% for R+/- 3 and 88.15 ± 1.32% 
for R+/- 1.5). In addition, the gradual increase in GFP signal indicated the efficacy of 
the transfection under the different conditions tested (Figure 4.3D).  
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Figure 4.3 – CHO-S cells transfection with lipoplexes at R+/- 5, 3, 1.5 in the 
microfluidic device. (A) Large scan at 4x magnification of the whole microchip with 
1495 anchored droplets. Scale bar: 200 µm. (B) Distribution of the number of cells 
per droplet (bars), and best fit to a Poisson distribution (dashed line). (C) View of a 
typical anchor at 10x magnification, showing an overlay of bright-field and DAPI 
(live) and TRITC (dead) signals. Images at first (0h) and final (62h) time of 
experiment are shown. Bar graphs show CHO-S viability for different conditions. 
There is no significant difference (ns) of cell viability between different conditions 
by Wilcoxon rank sum test at 5% significance level. Scale bars represent 50 µm. 
Results represent means ± S.D., n = 2. (D) For transfection analysis, FITC filter 
was used to quantify GFP production and TRITC to track all cells during the time-
lapse. Shown here are overlays of bright field and FITC images at time 0, 24, 48 
and 62 h. 
Others droplet-based microfluidic devices was explored in previous studies 
with different cell lines, showing their capacity to track cells for long culture period 
(Annex III), however cell viability and transfection efficiency was compromised.  
The platform contrasts with other conventional approaches in well-plates or in 
bioreactors, where cell productivity is usually assessed at the population level (e.g. 
ELISA or western blot etc.). Alternatively, the standard protocols for assessing 
single cell protein production make usually use of flow cytometry, which limits the 
possibility to obtain information of the cell history in culture and protein production 
kinetics.  
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Droplet microfluidics provide unique platform for cell encaspulation, biological 
isolation and tracking in culture. However, to date, the capability of droplet 
microfluidics to support the transfection and the culture of single genetically 
engineered animal cells has barely been investigated (22). For instance, while 
recent studies have demonstrated the electroporation (23) or chemical- based (12) 
genetic modification of single cells in droplets, the cells were cultivated off-chip 
after transfection. Consequently, it was not possible to correlate the initial cell 
properties to the GFP production efficiency.   
In contrast to other conventional tools, the integrated platform used in the 
present study enabled the individualization, the in situ transfection as well as to 
support the long term culture of GFP producing CHO-S population. It was thus 
possible to follow on line the recombinant protein production in individualized cells, 
starting from the time of their transfection to the end of the culture period (Figure 
4.3D).  
3.3. Kinetics of GFP Production at Single CHO-S Level Revealed Distinct 
Populations 
 The unique capability of the integrated culture platform for dynamically 
tracking individual CHO-S enabled to obtain a more complete view of the evolution 
of GFP production during the culture period. At first, we find the cell distribution 
according to GFP production for each loop of time lapse (each 2h) (Figure 4.4A, 
boxplot graphs). Then, since the culture platform let tracking of each cell, we can 
obtain the evolution of GFP production for each cell during all time lapse (Figure 
4.4B, line graphs). The kinetics of GFP production by cells transfected with 
lipoplexes R+/- 5, 3 and 1.5 (Figure 4.4) showed similar conditions and trends. The 
broad distribution of the kinetics of GFP production suggests that distinct 
populations produced different levels of GFP. In addition, since all individual curves 
followed a first order kinetic (r2>0.9), the rate of GFP production was not dependant 
of its relative intensity at the beginning of the culture period (Supplementary Figure 
S.1).  
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Figure 4.4 - Kinetics of GFP production during the culture period of CHO-S cell in 
single-cell platform. (A) Boxplots presenting the signal intensity for cells transfected 
with the lipoplex R+/- 5, 3 and 1.5 at each time step (each 2h). This is how flow 
cytometry would present the data. (B) The same data where the signal for each cell 
at the beginning of the experiment is subtracted from the signal as a function of 
time. The bold red line represents the evolution of the mean GFP production of the 
population. 
To compare the mean of GFP production by CHO-S cell population 
transfected with lipoplexes R+/- 5, 3 and 1.5, it was plotted in the same graph the 
three means in Figure 4.5. As a result, it was found the average rate of GFP 
production by the population transfected with R+/- 5 was significantly higher (1.5 
fold) in comparison to the other types of lipoplexes (i.e. R+/- 3 and R+/- 1.5) (Figure 
4.5).  
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Figure 4.5 – The comparison of GFP mean production by cells transfected with 
lipoplexes R+/- 1.5, 3 and 5, during the culture period in single-chip platform. The 
error bars represent the difference between replicas from each lipoplex condition 
(n=2).   
The formation of lipoplexes involves the electrostatic interaction between the 
positive charge of cationic lipids and the negative charge of the recombinant DNA 
(24). Consequently, the net charge of the liposome is significantly decreased after 
DNA complexation, leading to a decrease association with the cell membrane ( i.e. 
negatively charged) (25). Consistently, it was found that lipoplexes R+/- 5, which 
presented positive charge, transfected better the cells than R+/- 3 and 1.5 with 
negative charge. 
Then, in order to better distinguish the different subtypes within the whole 
CHO-S population, the evolution of the GFP signal distribution was more deeply 
analyzed. First, it was found that the spreading of the GFP intensity per cell 
followed a Poisson law, which median slightly shifted to higher values during time 
in culture (Figure 4.6A). To qualitatively measure this shift to right, we calculated 
the skweness of GFP intensity distribution over culture time (Figure 4.5B). 
Skewness is a measure of the asymmetry of the data around the sample mean. 
Thus, if the skewness is positive, the data are spread out more to the right of the 
mean than to the left. The skewness of a distribution is defined as (Equation 4.1): 
s =
𝐸 (x − μ )3
𝜎3
      (Equation 4.1) 
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where µ is the mean of x, σ is the standard deviation of x, and E(t) represents the 
expected value of the quantity t. Therefore, Figure 4.6B showed a positive skew, 
which Pearson's moment coefficient of skewness increased linearly with the time in 
culture. A threshold was determined in the mean of the GFP signal distribution, in 
which the right side is composed by the high producer cells (HPs) and the left side 
is composed by the low producers cells (LPs) (Figure 4.6C). Thus, the results 
demonstrated that a part of the CHO-S population produced GFP at a significantly 
higher level than other cells (LPS) (Figure 4.6D). Of note, the HPs were evenly 
distributed within the chip (Supplementary Figure S.2). 
The analysis of the GFP production at single cell level revealed that CHO-S 
contained a distinct sub-population producing higher level of GFP (HPs), whatever 
the type of lipoplexes used to recombinant DNA delivery (Figure 4.6D). Several 
cellular parameters can contribute to the heterogeneous level of recombinant GFP 
production rate, which include 1) the amount of internalized plasmids 2) the rate of 
RNA transcription, 3) the rate of RNA translation (5). In this study, the contribution 
of the rate of recombinant protein formation and the cell growth inducing plasmid 
dilution are considered minimal (5). Moreover, considering identical DNA delivery 
conditions in droplets containing the same lipoplex, the rate of GFP 
transcription/translation emerges as a potent parameter promoting the 
heterogeneity in the level of GFP production (5). 
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Figure 4.6 - Distribution of GFP production on the single-cell level (A) Histograms 
of the increase in GFP signal (Δl) for cells transfected with lipoplexes R+/- 5 at 
culture-times t = 12h (red curve), t = 32h (green curve) and t = 62 h (blue curve). 
(B) The asymmetry towards the high values is quantified through the Skewness 
parameter, which is found to increase linearly in time.  (C) The skewness of GFP 
intensity distribution at the final instant (t=62 h) could be used to define a threshold 
that divides the population into low-producing and high-producing cells. (D) Time 
evolution of the signal due to the high producers and other cells. Data for other 
conditions (R+/- 3 and 1.5) are similar. Results represent means ± S.D., n = 3.   
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3.4. Characterization and Recovery of the High GFP Producers  
To characterize the high GFP producers (HP), the influence of the different 
types of lipoplexes was investigated on the relative abundance of HPs and their 
specific productivity. Figure 4.7A showed that a higher percentage of HPs was 
found using lipoplexes R+/- 5 (15.27% ± 1.77), in comparisons of R+/- 3 and R+/- 1.5 
(8.72% ± 1.55 and 4.88% ± 0.12, respectively). Next, we compared the specific 
GFP productivity of HPs for each lipoplex used R+/- 5, 3 and 1.5 (Figure 4.7B). It 
was found that the GFP productivity was about 1.5 higher for R+/- 1.5 than R+/- 5 
and R+/- 3, after 30h of cell culture (Figure 4.7B). The results suggest that the 
higher productivity of CHO-S population transfected with R+/- 5 (Figure 4.5) was 
mainly due to higher percentage of HPs within the whole population. Despite 
higher productivity, the contribution of the HPs in R+/- 1.5 condition (Figure 4.7B) 
was not sufficient to reach the same total level of GFP production than for R+/- 5 
(Figure 4.5).  
 
Figure 4.7 - Characterizing high GFP producers. (A) Percentage of total cells 
characterized as HP for each of the lipoplex conditions indicate a decreasing 
number of high producing cells with increased DNA charge. (B) The specific 
productivity for the three conditions shows that the GFP production per transfected 
cell increases with increased DNA charge. (C) Size difference between high 
producers and low producers for different conditions. Means statistically significant 
different by Kruskal-Wallis (B) or by Wilcoxon rank sum test (A and C) at 5% 
significance level were flagged with an asterisk (*). Error bars represent the values 
for the two independent experiments. 
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To better prove the properties distinguishing HPs from the other cells of the 
population (low producers, LPs), their initial size distribution was first compared 
(Supplementary Figure S.3). Figure 4.7C showed that the average HPs area was 
at least 15% higher than LPs whatever the type of lipoplexe tested. In turn, the 
cells transfected with R+/- 1.5 and 3 lipoplexes had HPs significantly bigger than 
LPs. In addition, it was found that the initial area of HPs transfected with R+/- 1.5 
was significantly larger than those with R+/- 5 and 3 (Figure 4.7C). Thus, the cell 
size emerged as an important parameter leading to the emergence of HPs in the 
transfected CHO-S population. Thus, in the present work, it was found that the 
initial cell size of HPs correlated high GFP production (Figure 4.6C), which suggest 
that HPs are in a distinct cell cycle phase than the other cells of the population 
(5,26). Indeed, the specific productivity of CHO is usually found greater in G2/M 
(i.e. early-mid exponential phase) (26). During this cell cycle phase, the cells are 
found larger and more rRNA are available for recombinant protein translation (27). 
Moreover, G2/M is associated with a loss of nuclear membrane integrity, facilitating 
the plasmid internalization through the endosomal pathway (28). Furthermore, as 
the cytoplasmic membrane is extending prior to mitosis, the decrease of its tension 
facilitates the endocytosis of nanoparticles (29). 
Lipofection provokes a distortion in the cell cycle, which show lower oscillation 
than non-transfectd cells (30). Moreover, liposome transfection increased the 
percentage of cells in S and G2/M phase (i.e. the phases were the cells displayed 
the highest diameter), at the expense of cells in G1 (30). In this study, it was found 
that the different types of lipoplexes differently affected the properties of HPs 
contained in the bulk of CHO-S. Indeed, a significantly higher percentage of HPs 
were found in R+/- 5 than R+/- 3 and 1.5 (Figure 4.7A). On the other hand, the GFP 
production by HPs was higher in cells transfected with lipoplex R+/- 1.5 than R+/- 5 
and 3 (Figure 4.7B). Because R+/- 5 displayed higher ζ, it favored increased 
lipoplexes/cell membrane interactions and, as a consequence, an increase 
percentage of HPs whitin the population. However, R+/- 1.5 showed higher GFP 
productivity despite lesser amount of lipoplexes interacting with CHO-S (i.e. due to 
lower ζ), since they enable the delivery of higher amount of plasmid to CHO-S 
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nucleus. In case of lipoplex R+/- 3, ζ and pDNA content is comprised between R+/- 5 
and R+/- 1.5, and so, CHO-S transfected under this conditions showed amount of 
HPs in cell population and specific productitvity comprised between the two other 
lipoplexes conditions. 
         Finally, in view of future functional analysis (transpritomic and proteomic 
investigations), protocol of a selective recovery from platform was used for the 
isolation of HPs off-chip. The procedure enabled to non-invasively recover 
fluorescent cells. Moreover, after one day in culture, the intensity of GFP within the 
isolated CHO-S was in a similar range as before the extraction, suggesting that 
cells retain viability and their GFP production capability. 
4. Conclusions  
A universal droplet microfluidic placed was used to assess the 
heterogeneities of CHO-S population transiently transfected with different types of 
lipoplexes. The devise enabled the combined single cell isolation, in situ 
transfection and culture for long time periods. A single cell analysis of GFP 
production kinetics revealed the presences of a subpopulation producing 
significantly high levels of recombinant proteins, whatever the properties on 
lipoplexes. The high producers showed increased cell size in comparison to the 
average population. The charge and the pDNA content of the different lipoplexes 
regulated differentially relative abundance of HPs in cell population (higher in 
lipoplexes with positive charge and less pDNA content) and GFP specific 
productivity of HPs (higher in lipoplexes with negative charge and more pDNA 
content).  
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7.  Supplementary data  
7.1. Lipoplexes per cell estimation  
To estimate the number of lipoplexes per cell, at first we estimated the 
number of liposomes synthesized for each condition: 1.85 µL (R+/- = 5), 1.11 µL 
(R+/- = 3) and 0.55 µL (R+/- = 1.5). Considering lipossomes with a spherical 
geometry and unimodal size distribution, the aggregation number is (31):  
𝑁 ≈
4𝜋[𝑅𝐶
2 +  (𝑅𝐶 − 𝑡)
2]
𝑎0
⁄  
where 𝑅𝐶 is the critical radius assumed here as the average hydrodynamic radii of 
50 nm, t is the bilayer hydrocarbon thickness of 4 nm (32) and 𝑎0 is the optimal 
value of surface headgroup area. In this case of mixed bilayer, 𝑎0 corresponded  
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the lipid cross-sectional area for DOTAP, DOPE and EPC are 0.7, 0.55 and 0.71 
nm2, respectively (31,32). The final lipid concentration of liposome was 2.27 mM. 
Thus, we used approximate 9.7 x 109 liposomes for R+/- = 5, 5.8 x 10
9 liposomes 
for R+/- = 3 and 2.9 x 10
9 liposomes for R+/- = 1.5.  
 In terms of lipoplexes, the system can generate a ternary phase system with 
single, double, and multiple bilayers, depending on the molar charge ratio (19). 
Analyzing the extreme conditions, R+/- = 5 formed around 20% of double bilayers 
and 80% “empty” liposomes, R+/- = 1.5 formed around 20% of multiple bilayers, 
66% of double and 14% “empty” liposomes. Thus, effectively R+/- = 5 and R+/- = 1.5 
contained about 6 x 105 lipoplexes / cell and 2 x 105 lipoplexes / cell, respectively.  
7.2. Graphics of GFP production by CHO-S cells  
 
Figure S.1 – GFP production kinetics characterization. An example of linear 
coefficient correlation distribution (r2) of GFP produced by CHO-S cells transfected 
with lipoplexes R+/- 5 for all single cells (blue columns) and for high GFP producers 
(red line) is exhibited. 
 
Figure S.2 - High GFP producers evenly distributed within the microchip. HPs are 
represented as red points on the microchip's map.    
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Figure S.3 - High GFP producers characterization in terms of cell-size. An example 
of graphs comparing size of HPs (red line) and all cell population (blue columns) 
for CHO-S cells transfected with lipoplexes R+/- 5 is shown. 
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Chapter V – Conclusions  
________________________________________________________________________________ 
In the first part of this work, droplet-based microfluidic system was applied to 
synthesize lipoplexes. In the second part, a single-cell platform was used to 
investigate transient transfection of CHO-S cells. We conclude that liposomes 
maintain their properties after processing in droplet system, allowing more 
advanced applications. Microchip design with thin serpentine channel or wide 
serpentine channel with a split region increase lipoplex homogeneity. This system 
allows the loading of larger amounts of pDNA in liposomes (R+/- 1.5) without 
changing lipoplexes properties (size, PdI and zeta potential), specially desired for 
gene therapy applications. Lipoplexes synthesized in droplet system with wide 
serpentine channel and split region, operating at ratio aqueous/oil flow rate 0.25 
and R+/- 1.5, 3, 5, 7, and 10, transfect DCs showing the transfection efficiency 
equivalent to that presented by lipoplexes produced by bulk method. In addition to 
transfecting, lipoplexes synthesized in droplet system also activate DCs. Therefore, 
the droplet-based microfluidic system shows as a potential tool to synthesize 
lipoplexes for cell lines transfection. The single-cell platform was shown to be 
efficient to transfect CHO-S cells by lipoplexes, while maintaining cells viability. 
With the single-cell analysis, it is possible to study the heterogeneities of CHO-S 
population, during transient transfection. The GFP production kinetics is tracked for 
each cell during culture time, allowing to determinate two different subtypes of cell 
population, high and low GFP producers. High producers increase cell size in 
comparison to the average population. The charge of lipoplexes shows an 
important role to transfect CHO-S, since the unique positive charged lipoplex R+/- 5 
produces more HPs. The amount of pDNA delivered affects the protein production, 
since R+/- 1.5 with more pDNA, increase GFP specific productivity of HPs. The 
universal platform shows as a powerful tool to investigate mammalian cell 
transfection and to identify / characterize high protein producer cells.  
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Chapter VI - Perspectives  
________________________________________________________________________________ 
 
Lipoplexes synthesized in the droplet-based microfluidic system were suitable 
to transfect dendritic cells. Moreover, the universal platform can be used to 
investigate mammalian cell transfection and heterogeneities in cell population. In 
this context, one future perspective envisaged for this work is to use the universal 
platform to transfect dendritic cells. The aim would be to investigate DCs 
transfection, characterize the transfected DCs and high-producer screening, in 
order to find the way to increase the DC transfection efficiency while providing cells 
activation. In general, this universal platform opens good perspectives to 
investigate the transfection of immune system cells, which frequently present a 
heterogeneous behavior and are hard-to-transfect cells, since they are usually 
provided by primary cell cultures. Another possible future work is to use the 
droplet-based microfluidic system to complex other nanoparticles with nucleic 
acids, which require more controllable environment. For example, chitosan 
nanoparticles are very sensible to changes in the solvent and in amount of nucleic 
acids, leading to precipitations in different complexation conditions. Thus, the 
controlled microenvironment generate in the droplet system could favor the 
synthesis of these complexes, even if in adverse conditions.      
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ANNEX I – Plasmid vectors 
_________________________________________________________________________ 
Positive control vector pEGFP-N1 from Clontech (Figure 1) is a plasmid with 
florescent tag for mammalian cell expression presenting bacterial resistance for 
kanamycin. This vector was used in Chapter III to quantify DC transfection 
efficiency.  
 
Figure 1 - Plasmid map of pEGFP-N1 Vector from Clontech.  
Positive control vector pmaxGFP from Lonza (Figure 2) is ideal positive 
control protein especially for fluorescence microscopy. The plasmid encodes the 
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green fluorescent protein from Pontellina sp. This vector was used in Chapter IV to 
obtain the kinetics of recombinant protein production by CHO-S cells.   
 
Figure 2 - Plasmid map of pmaxGFP Vector from Lonza.  
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ANNEX II –Preliminary studies in droplet microfluidic 
system to synthesize lipoplexes 
_________________________________________________________________________ 
Before investigating the lipoplexes synthesis in droplet-based microfluidic 
system, previous studies were carried out, such as investigation of flow rates to 
droplets formation in a water/oil emulsion using less expensive reagents and study 
of CL formation in different diluents in order to obtain nanoparticles with required 
physico-chemical characteristics to DC transfection.  
1. Study of flow rates for droplets formation  
For investigation of droplet formation in microfluidic system (Figure 3.1B, TC), 
two aqueous solutions were prepared with water added with green and red dyes in 
order to facilitate visualization of droplets and the mixing inside them. The oil phase 
of emulsion was composed of mineral oil from Vetec Química Fina (RJ, Brazil) with 
2% v/v of surfactant sorbitan monooleate (Span 80) from Sigma Aldrich (MO, 
USA). We should highlight that this oil phase was not chosen for complexation 
process due to the low biocompatibility of mineral oil. However, we decided to use 
it to estimate flow rates for droplets formation in microfluidic device because of the 
lower cost of these reagents than FC-40 oil and Pico-Surf 1.    
Thus, we studied several inlet flow rates for aqueous phase (Qaqueous) and for 
oil phase (Qoil) in the droplet-based microfluidic system thin serpentine channel 
(200 μm) and split region and (Figure 1 and Table 1). The solutions were 
introduced in each respective inlet by syringe pump, in which as aqueous phase 
was introduced the green and the red dye solution and as oil phase the mineral oil 
with Span 80. The following strategy was used to investigate the flow rates: at first 
the oil phase flow was fixed at 2 μL min−1 while aqueous flow rate varied from 0.1 
to 4 μL min−1. Then, the inverse was made, the aqueous flow rate remained 
constant at 0.67 μL min−1 and the oil phase flow varied from 0.1 to 19.2 μL min−1, 
as described in Table 1. The fixed flow rates of aqueous and oil phases and the 
microfluidic device were chosen based on the previous study realized by (1), which 
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used Qoil = 2 μL min
−1 and Qaqueous = 0.67 μL min
−1 to produce droplets in a similar 
droplet-based microfluidic system.  
Table 1 - Variation in flow rates Qaqueous (aqueous phase composed of green and 
red dye in water) and Qoil (oil phase composed of mineral oil with 2% v/v of 
surfactant Span 80) for droplet formation in the droplet-based microfluidic system 
with serpentine-TC and split region (Figure 3.1B).  
Flow rates study 
Fixed Qoil = 2 μL min
−1
 Qaqueous = 0.67 μL min
−1
 
Variant Qaqueous (μL min
−1
) Qoil (μL min
−1
) 
 0.1 0.1 
 0.29 0.67 
 0.48 1.4 
 0.67 2 
 1.11 4 
 1.55 8 
 2 19.2 
 3   
 4 
Flow rate combinations were observed and images were taken by using the 
trinocular stereo microscope from Bel Photonics (STMPRO-T model, Monza, Italy). 
For each moment in which system operating conditions changed, it was waited five 
minutes for system stabilization. General behaviors observed in the droplet-based 
microfluidic system were illustrated in Figure 1 and described as follow:  
(i) If the flow rate is considered good, droplet formation will be well defined and 
similar to that seen in Figure 1A; 
(ii) If the ratio between Qaqueous and Qoil increases, droplet size tends to increase 
(Figure 1B) until reach a parallel flow streams (Figure 1C).  
(iii) However, if this ratio decreases (Qaqueous/Qoil), droplet size tends to decrease 
(Figure 1D) until the oil phase invades aqueous phase inlet channels (Figure 
1E). We also observed an intermediate stage between Figures 1D and E not 
shown, in which system was unstable altering in droplet formation and in oil 
phase entering into aqueous phase inlets. 
As a result, the range of Qaqueous between 0.48 to 2 μL min
−1 and Qoil fixed at 2 
μL min−1 was chosen for further assays of water fraction estimation with FC-40 oil 
with 5% v/v of surfactant Pico-Surf 1 as oil phase in droplet-based microfluidic 
system.  
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Figure 1 – Images of droplet formation with aqueous phase composed of green 
and red dye in water and oil phase composed of mineral oil with 2% v/v of 
surfactant Span 80 in the droplet-based microfluidic system with serpentine-TC 
and split region (Figure 3.1B). Following droplet behaviors were observed in the 
microfluidic system: (A) ideal droplets when flow rates were Qoil = 2 μL min
−1 and 
Qaqueous = 0.67 μL min
−1, large droplets when Qoil = 2 μL min
−1 and Qaqueous = 2 μL 
min−1 (B), until reached a parallel flow when Qoil = 2 μL min
−1 and Qaqueous = 3 μL 
min−1 (C), and small droplets were formed decreasing Qaqueous to 0.29 μL min
−1 with 
Qoil = 2 μL min
−1 (D), until the oil phase invaded aqueous phase inlet in Qoil = 2 μL 
min−1 and Qaqueous = 0.10 μL min
−1(E).  
2. Cationic liposome diluent 
Cationic liposomes composed of EPC/DOTAP/DOPE (50/25/25 % molar, 
respectively) were produced in a cross-junction microfluidic device by a single 
hydrodynamic focusing, like BALBINO et al. (2) (Figure 3.1A). Lipid dispersion was 
inserted in the central entrance and in the two lateral inlets were introduced the 
aqueous phase, which could be water, PBS buffer solution or OptiMEM culture 
medium (Figure 3.1A). The three lipids were dispersed in anhydrous ethanol to 
achieve 25 mM of total lipid concentration, following the protocol established by 
Rigoletto et al. (3). The lipid dispersion was injected into the system at 10.92 μL 
min−1 in a glass syringe (Hamilton, NV, USA, 1 mL) via syringe pump (KDScientific, 
model KDS-200, USA). Simultaneously, two glass syringes (Hamilton, NV, USA, 
2.5 mL) with aqueous phase (water, PBS buffer or OptiMEM) were injected at 54.6 
μL min−1 into two sides of T-chip. Liposome samples were collected from the exit 
and leaved for at least 2 hours at 4 °C. Then, samples were collected to physico-
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chemical characterization of size, polydispersity and zeta potential in Zetasizer 
equipment, as shown in Table 2 and Figure 2. 
The cationic liposomes obtained using water as aqueous solution had small 
polydispersity (0.202), positive zeta potential (59.9 mV) and small size (76.6 nm), 
like showed in Table 2. On the other hand, liposomes obtained using PBS buffer as 
aqueous solution had higher polydispersity (0.322), larger size (approximately 85% 
of the population at 135.8 nm and the other 15% at 376.4 nm) and zeta potential 
slightly smaller (41.8 mV) than those obtained in water (Table 2). Similarly to PBS 
buffer solution, cationic liposomes formed in OptiMEM had higher polydispersity 
(0.257), larger size (approximately 99% of the population at 88.1 nm and the other 
1% at 532.2 nm) and smaller zeta potential (38.6 mV) than those obtained in water 
(Table 2). In addition, Figure 2 showed the size distribution graphs of cationic 
liposomes in intensity and number for all conditions. Graphs demonstrated more 
clearly the polydispersity of liposomes formed in PBS and in OptiMEM that had two 
populations, and liposomes synthesized in water had only one homogeneous 
population. Because of these characteristics, water indicated to be more suitable 
as aqueous solution than PBS and culture medium for cationic liposomes formation 
in the cross-junction microfluidic device. Moreover, complexing process, 
incorporation of DNA into liposomes, tends to increase more nanoparticles size 
and polydispersity, leading to decrease internalization by DCs, and consequently, 
in transfection efficiency (4).  
 
 
 
 
 
 
 
 
122 
 
 
Table 2 - Physico-chemical properties of cationic liposomes obtained by single 
hydrodynamic focusing in cross-junction microfluidic device using as aqueous 
phase water, OptiMEM culture medium or PBS buffer solution.  
Cationic 
liposomes 
Mean diameter (± S.D.) nm and distribution (± S.D.) % 
Pdl
(iii)
 
Zeta 
potential 
Intensity
(i)
 Number
(ii)
 (± S.D.) mV 
PBS 
444.7 ± 46.5 (67.4 ± 8.4) 
146.1 ± 33.1 (32.7 ± 8.4) 
376.4 ± 26.5 (15.3 ± 0.1) 
135.8 ± 31.0 (84.7 ±0.1) 
0.322 ± 0.059 41.8 ± 0.0 
OptiMEM 
129.8 ± 34.4 (76.4 ± 12.6) 
479.8 ± 186.0 (23.6 ± 12.6) 
88.1 ± 0.4 (98.9 ± 1.3) 
532.2 ± 270.2 (1.1 ± 1.3) 
0.257 ± 0.066 38.6 ± 1.7 
Water 119.7 ± 16.7 (100 ± 0) 76.6 ± 17.8 (100 ± 0) 0.202 ± 0.038 59.9 ± 2.1 
Results represent means ± S.D., n = 2.  
(i) 
Intensity-weighted average diameter and distribution (I-distribution).
  
(ii)
Number-weighted average diameter and distribution (N-distribution). 
(iii)
 PdI: Polydispersity index of samples vary in ascending order from 0 to 1. 
 
            A                                                               B 
 
Figure 2 - Intensity-weighted distribution (A) and number-weighted distribution (B) 
of cationic liposomes obtained in water, OptiMEM culture medium or PBS buffer 
solution as aqueous phase. The dashed and solid lines in each graph represent 
one independent size distribution (n=2). 
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ANNEX III – Preliminary studies in droplet microfluidic 
system to transfect CHO-S cells 
_________________________________________________________________________ 
Before reach the system presented in Chapter III to transfect CHO-S cells, 
others cells and microdevices were explored, as showed in this annex. However, 
the low viability or transfection of cells lead us to leave them. Even though, the 
device showed a potential to understand key parameters that influence in vitro 
mammalian cells transfection process. Thus, a droplet-based microfluidic system 
was used to transfect in vitro mammalian cells (smooth muscle cells (SMCs), 
mesenchymal stem cells (MSCs) and lymphoma cells (S49.1)) under a 3D 
microenvironment provided by hydrogels (collagen and agarose) as extracellular 
matrices. Additionally, this system also provided a study of cells morphology by 
changing cells concentration (from 0.1 to 0.5 x 106 cells/mL), using Rho–ROCK–
myosin inhibitors (like blebbistatin and Y27632) and modifying hydrogel stiffness 
(1.2 and 6 mg/mL collagen concentration); being a potential tool to signalize 
transfection pathways. 
1. Objectives 
The general purpose of this part of work was to develop a microchip to 
transfect mammalian cells in vitro within soft 3D droplets hydrogel, using cationic 
liposomes incorporated with nucleic acids as nanovectors. Thus, with this system, 
we are able to investigate and compare transfection parameters in different types 
of mammalian cells, like transfection kinetics and pathways, optimum molar ratio 
between nanoparticles/nucleic acids and nanoparticles/cell.  
2. Materials and methods  
2.1. Materials 
Collagen rat tail type I to make hydrogel droplets for adherent mammalian 
cells and agarose (1% w/v) as an extracellular matrix for non-adherent mammalian 
cells. Oil phase was composed by Fluorinert Eletronic Liquid FC-40 from 3M with 
surfactant poly(ethylene glycol-ran-propylene glycol) (PEG-ran-PPG) at 1 % (w/v). 
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Cationic liposomes consisted of egg phosphatidylcholine (EPC), 1,2-dioleoyl-3-
trimethylammonium propane (DOTAP) and 1,2-dioleoylphosphatidylethanolamine 
(DOPE)  from Lipoid (Germany), were complexed with DNA (Clontech pGFP 
Vector) encoding green fluorescent protein (GFP). Cells were marked with 
CellTrackerTM red CMTPX or  Live/Dead® Viability/Cytotoxicity Assay Kit both from 
Life Technologies. 
2.2. Microfluidic device fabrication 
The microfluidic device (Figure 1) was fabricated following protocols 
established at Professor Charles’ laboratory. We used dry film photo-lithography, 
which allows the simple fabrication of complex geometries (1). Briefly, a solid film 
of photo-resist is laminated on a glass slide, using an office laminator. It is then 
exposed to UV light through a specially designed mask that corresponds to the 
desired channel shape. This then serves as a mold for patterning the channels 
themselves, which corresponds to the top part of the chip made with 
poly(dimethylsiloxane) (PDMS) (see e.g. SQUIRES e QUAKE (2)). The bottom part 
was a thin film of PDMS with five hundred droplet traps, obtained from a metal 
model designed in a Micro Engraving Machine, in which the polymer dried bonded 
over a glass slide. The top and bottom part of PDMS are then bonded and the 
inner surfaces are functionalized with silane groups that provide a hydrophobic 
environment that is suitable for the generation and manipulation of aqueous 
droplets in oil (1). 
 
Figure 1 - Droplet-based microfluidic system. 
2.3. Adherent mammalian cells transfection in the droplet-based microfluidic 
system 
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Smooth muscle cells (SMCs) and mesenchymal stem cells (MSCs) were 
cultivated until be in confluence and then inserted in microchip with collagen. 
SMCs and MSCs were mixed with collagen in 1:3 ratio and then inserted in the 
microdevice shown in Figure 1. Cell concentration varied from 0.1 to 0.5 x 106 
cells/mL and collagen concentration 1.2 and 6 mg/mL. In this step, the system was 
kept at -4 ºC to avoid collagen gelation before droplets formation. The cells 
suspension was pumped in the system by the first entrance (Figure 1) at 5 µl/min, 
while two oil flows were incorporated by second entrance at 5.8 µl/min to form 
droplets in a flow-focusing design, and by third entrance at 35 µl/min to pull 
droplets to be trapped in the chamber and to increase their covering with 
surfactant, avoiding coalescence. After fill all traps with hydrogel droplets, the 
system was incubated at 37 ºC to collagen gelation, and then we changed the 
continuous phase from oil to aqueous phase. For this, about 2 ml of FC40 oil pure 
(without surfactant) was passed through the system at 40 µl/min to wash droplets 
covered with surfactant, and then, at least 100 µl culture medium was inserted at 1 
µl/min. Depending on what we wanted to investigate, lipoplexes or culture inhibitors 
might be diluted in this medium. Then, images from the cells inside hydrogel 
droplets were taken by a motorized microscope (Nikon, Eclipse Ti-E) to study cell 
behavior over time.  
2.4. Non-adherent mammalian cells transfection in the droplet-based microfluidic 
system 
Likewise, 0.25 x 106 lymphoma cells (S49.1)/ml were inserted in the system, 
but in this case, because of involving non-adherent cells, agarose was used as 
hydrogel. Thus, the system was kept on 37 ºC during droplets formation, and then 
put at 4 ºC for agarose gelation. After that, phases were changed from oil to 
aqueous composed by medium with or without lipoplexes. Cells were also marked 
with live/dead staining to study cells viability, besides transfection kinetics. Images 
were taken by the motorized microscope to investigate these behaviors of S49.1 
over time. 
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3. Results and discussion 
3.1. Smooth muscle cells and mesenchymal stem cells in collagen microdroplets 
At a first moment, we started to work with adherent mammalian cells looking 
for more complex cells transfection applications, like induced pluripotent stem (iPS) 
cells reprogramming (3). However, adherent mammalian cells need a growth matrix 
like collagen to regulate integrin-mediated adhesion to the extracellular matrix, to 
bind growth factors to their receptors (4) and to mediate cells spreading (5), among 
other things. Additionally, cellular morphology is closely linked to transfection 
efficiency. Cellular microenvironment can modulate non-viral gene delivery, since 
proteins that promoted well spread cells resulted in complexes being trafficked to 
the nucleus and enhanced gene transfer (6). And also the act of integrin 
engagement and spreading itself may have an effect on cells uptake of non-viral 
vectors (7). Thus, as preliminary results (data not shown), we cultivated DC3F cells 
(Chinese hamster lung fibroblasts) inside and on the top of collagen, in and off 
chip, aiming to investigate cell morphology. Then, we started to work with Smooth 
Muscle cells (SMCs) in chip to investigate the behavior of a high contraction cell 
model according to matrix stiffness. For this, we filled the microchamber like 
showed in Figure 2 with five hundred collagen droplets containing cells inside, 
providing a huge number of experimental repetitions to be analyzed. In this first 
moment, we analyzed the results only in few droplets (n=10 to 20), but in the future 
the purpose is to use computational tools for image analysis, like MATLAB, to 
analyze more samples and increase the experimental accuracy of results.   
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Figure 2 – Microchamber with 500 cylindrical traps with 250 µm of diameter by 250 
µm of height. 
The first aspect tested was to change the matrix stiffness by changing 
hydrogel concentration. Thus, we fixed SMCs concentration at 4x106 cells/ml and 
compared their mechanism in the early hours of incubation in 1.2 mg/ml and 6 
mg/ml of collagen in the matrix (Figure 3). As we can see in the images, when 
SMCs were cultured in a softer matrix (1.2 mg/ml) in 5 hours they spread (Figure 3 
B), in 16 hours of incubation they shrink the hydrogel with their strong force traction 
(Figure 3 C) and, in 1 day, almost 90% of droplets are like an agglomeration ball of 
cells and collagen (Figure 3 D). On the other hand, when SMCs were cultured in a 
more rigid matrix (6 mg/ml), they spend more time to start to spread (around 16 
hours incubation, Figure 3 G) and, consequently, to make these typical cell 
agglomerations showed in Figure 3 H. About 60% of cells are in these cluster 
structures after 1 day in culture.     
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Figure 3 – Time-lapse images from 0, 5, 16 and 24 hours of smooth muscle cells 
(Ccell = 4x10
6 cells/ml) cultivated in collagen hydrogel droplets at 1.2 mg/ml (A, B, C 
and D) and 6 mg/ml (E, F, G, H).    
Then, since spreaded cells could provide nanoparticles traffic to the nucleus 
(6), we transfected SMCs in the same cell concentration (4x106 cells/ml) and 
collagen droplets at 6 mg/ml (Figure 4), in order to stay a larger period of time in a 
favorable morphology to transfection. We complexed cationic liposomes 
EPC/DOTAP/DOPE (50/25/25% molar) with pDNA encoding green fluorescent 
protein (GFP), in a molar charge ratio between nucleic acids and cationic lipids 
(R+/-) at 5 and around 1.3x10
-4 µg of DNA/droplet. However, as shown in Figure 4C 
and D, cells in agglomerated structures make difficult to quantify cells transfected 
for over than 1 day incubation, seeing that the green fluorescence comes from a 
cluster, not from an individual cell.   
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Figure 4 – Images of smooth muscle cells (Ccell = 4x10
6 cells/ml) cultivated in 
collagen at 6 mg/ml and transfected with lipoplexes (DNA/cationic liposomes at a 
molar charge ratio of R+/-=5 for 0 day (A), 1 day (B), 2 days (C) and 3 days (D).  
After, in such a way to avoid these cluster structures, we decreased SMCs 
concentration from 4 to 1x106 cells/ml, but study cell behavior also in the two 
collagen concentration, 1.2 mg/ml (Figure 5 A and B) and 6 mg/ml (Figure 5 C and 
D) for 1 day. As a result, almost 70% of droplets did not form an agglomeration 
after 1 day incubation (Figure 5 B and D), i.e. fewer cells in droplets, in both 
collagen concentrations, slowed down hydrogel shrink. Nevertheless, cell 
distribution on microdroplets follows Poisson distribution (8), which makes that 
many droplets in the chamber do not have cells inside hydrogel, decreasing results 
accuracy. 
 
 
 
 
 
 
 
 
131 
 
 
A B 
  
C D 
  
Figure 5 – Images from 0 and 1 day incubation of smooth muscle cells 1x106 
cells/ml cultivated in collagen hydrogel droplets at 1.2 mg/ml (A and B) and 6 
mg/ml (C and D).   
Thus, to maintain hydrogel droplets without shrinking but assuring the 
majority of 500 droplets in the chamber with SMCs, we inserted 2.5x106 cells/ml 
mixed with 6 mg/ml of collagen in microdevice, reaching around 10 cells/droplet 
(Figure 6). About 95% of hydrogel droplets stayed attached to the trap surface for 1 
day incubation even with cells spreaded, like showed in Figure 6 A. Even though, 
when cells are stained with cell tracker to facilitate cell localization and added with 
lipoplexes to transfect, they did not spread as we can verify in Figure 6 B. 
Continuous exposure of cells to fluorescent probes, such as rhodamine, can lead 
to be cytotoxic for some type of cells (9); and also cationic liposomes, more 
specifically cationic lipids (10,11). Therefore, cells maybe react against cytotoxic 
from these reagents, not spreading.   
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Figure 6 – Images incubation of smooth muscle cells 2.5x106 cells/ml cultivated in 
collagen hydrogel droplets at 6 mg/ml for 1 day without staining (A) or with cell 
tracker and lipoplexes (B).  
Hence, we transfected SMCs in this cell concentration (2.5x106 cells/ml), 
collagen droplets at 6 mg/ml and cells marked with a tracker (Figure 7). The 
lipoplexes cationic liposomes/pDNA were also in a molar charge ratio at (R+/-) at 5 
and around 1.3x10-4 µg of DNA/droplet. Almost 30% of cells were transfected after 
1 day incubation and in 7 days it increased to 35% of transfection, but in 10 days of 
transfection does not increase more, maybe because they do not proliferate more.  
A B C D 
    
 
   
Figure 7 – Images of smooth muscle cells (Ccell = 2.5x10
6 cells/ml) stained with cell 
tracker, cultivated in collagen at 6 mg/ml and transfected with lipoplexes 
(DNA/cationic liposomes at a molar charge ratio of R+/-=5) for 0 day (A), 1 day (B), 
7 days (C) and 10 days (D). Detached green fluorescent images of transfected 
cells in their respectively day of incubation. 
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Cells inside 3D microenvironment interact with cell-surface receptors, 
extracellular matrix and cell-cell adhesions, stimulating to generate changes in the 
actin cytoskeleton at primarily through engagement of clathrin endocytosis 
pathways, more specifically, RhoGTPases proteins (12). So, as a first step, we 
investigate few parameters, like hydrogel and cell concentration, to modify matrix 
stiffness and, consequently, activate molecular pathways related to actin 
cytoskeleton, which can regulate internalization and effective intracellular 
processing of nanoparticles resulting in an efficient gene transfer (6). But after, as a 
second step, we started to use few cell inhibitors to study cell behavior with regard 
to specific pathways related to matrix stiffness (13).  
Cell spreading increase with cell traction force, RhoA activity and is also 
controlled by extracellular matrix stiffness. So, when grown in soft matrices, many 
cell types exhibit less spreading, as well as, reductions in proliferation, traction 
forces, stress fibers, and focal adhesions (14). However, Mih et al. (13) showed that 
putting some Rho ROCK inhibitors (like blebbistatin and Y27632) in fibroblasts 
cultivated in soft matrices generate an “excessive” contractile force that switches 
actomyosin from suppression to promote cell proliferation in soft matrices. We 
remarked by time-lapse images (Figure 3) with high SMCs concentration (4x106 
cells/ml) in a very soft matrices (Ccollagen = 1.2 mg/ml) that collagen hydrogel is so 
soft that cells cannot stay a long time spreaded. Thus, we put 100 µM of Y27632 
inhibitor in this cell culture conditions to promote cell proliferation and spreading 
even in soft matrix (Figure 8) and, maybe in future steps, we can use the same 
strategy to determinate the transfection pathways.  
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Figure 8 – Images of smooth muscle cells (Ccell = 4x10
6 cells/ml) added with 
Y27632, cultivated in collagen hydrogel droplets at 1.2 mg/ml for 0 (A) and 16 
hours (B). 
As we can see in Figure 8 B, after 16 hours of incubation SMCs continue 
spreaded (approximately 90% of microdroplets) and without making an aggregated 
structure like showed in Figure 3 C. On the other hand, the spreading morphology 
of smooth muscle cells is different from Figure 3 B to Figure 8 B, because of 
different pathways used to activate actin cytoskeleton. In fact, members of 
RhoGTPase family are key regulatory molecules that link surface receptors to the 
organization of the actin cytoskeleton; more specifically RhoA forms stress fibers 
and focal adhesion, Rac1 provides structures like lamellipodia and Cdc42 like 
filopodia (12). According to images shown in HALL (15) work, in the case of SMCs 
without inhibitors (Figure 3B) it seems that RhoA pathway is activated, since 
spreading is only regulated by matrix stiffness (14); on the other hand, SMCs with 
Y27632 inhibitor (Figure 8 B) seems to activated Cdc42 pathway, forming 
protrusions like filopodia. And also  LI; ZHOU e GAO (16) showed that small 
molecule inhibitors Y27632 markedly enhanced Cdc42 activity and the association 
of p-ERM with activated Cdc42, increasing cell motility.  
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In addition, for mesenchymal stem cells microenvironments appears to be an 
important for reprogramming them, for example, soft matrices that mimic brain 
provide neurogenic phenotypes, stiffer matrices that mimic muscles providing 
myogenic and comparatively rigid matrices that mimic collagenous bone prove 
osteogenic (17). Thus, we cultivated MSCs at 4x106 cells/ml inside collagen 
microdroplets at 1.2 mg/ml for 1 day, without inhibitors (Figure 9 A and B), with 10 
µM of Y27632 (Figure 9 C and D) and with 33 µM of blebbistatin (Figure 9 E and 
F). As a result, the positive control, i.e. without adding inhibitors, 40% of cell 
microdroplets maintained spreaded and without shrink for 1 day like showed in 
Figure 9 B. When added Y27632, 65% of MSCs microdroplets were spreaded like 
in Figure 9 D, and when added blebbistatin, 90% of hydrogel droplets with MSCs 
are like showed in Figure 9 F. Thus, blebbistain seems to be the most efficacy 
inhibitor for MSCs to not shrink, but differently from the other Rho ROCK inhibitor 
(Y27632), cells with blebbistain do not spread well in soft matrix (Figure 9 D and 
F). ENGLER et al.  (17) also added blebbistain in naïve MSCs cultured in matrices 
with different elasticity, concluding that blebbistain blocks cell spreading in every 
matrix tested. 
In addition, for mesenchymal stem cells microenvironments appears to be an 
important for reprogramming them, for example, soft matrices that mimic brain 
provide neurogenic phenotypes, stiffer matrices that mimic muscles providing 
myogenic and comparatively rigid matrices that mimic collagenous bone prove 
osteogenic (17). Thus, we cultivated MSCs at 4x106 cells/ml inside collagen 
microdroplets at 1.2 mg/ml for 1 day, without inhibitors (Figure 9 A and B), with 10 
µM of Y27632 (Figure 9 C and D) and with 33 µM of blebbistatin (Figure 9 E and 
F). As a result, the positive control, i.e. without adding inhibitors, 40% of cell 
microdroplets maintained spreaded and without shrink for 1 day like showed in 
Figure 9 B. When added Y27632, 65% of MSCs microdroplets were spreaded like 
in Figure 9 D, and when added blebbistatin, 90% of hydrogel droplets with MSCs 
are like showed in Figure 9 F. Thus, blebbistain seems to be the most efficacy 
inhibitor for MSCs to not shrink, but differently from the other Rho ROCK inhibitor 
(Y27632), cells with blebbistain do not spread well in soft matrix (Figure 9 D and 
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F). ENGLER et al. (17) also added blebbistain in naïve MSCs cultured in matrices 
with different elasticity, concluding that blebbistain blocks cell spreading in every 
matrix tested.  
A                                                                            B 
                
C E 
  
D F 
  
Figure 9 – Images of mesenchymal stem cells (Ccell = 4x10
6 cells/ml) cultivated in 
collagen hydrogel droplets at 1.2 mg/ml for 0 and 1 day without inhibitors (A and 
B), added with Y27632 (C and D) or with Blebbistatin (E and F).  
Furthermore, this study with adherent mammalian cells will help in the next 
step of the PhD project, since collagen seems to be an adequate support for 
dendritic cells transfection (18).  
3.2. Lymphoma cells in agarose microdroplets  
After study adherent mammalian cells, we studied non-adherent mammalian 
cells, such as lymphoma cells (S49.1), to consider the application of the same 
microchip to transfect both mammalian cells types. In this case, the hydrogel used 
137 
 
 
was agarose, because non-adherent cells do not need a complex extracellular 
matrix to attach, interact with other cells or soluble factors, as provided by collagen.  
As lymphoma cells are smaller than SMCs and MSCs, at first, we studied the cell 
concentration with which we can count cells after proliferate for some days, but 
also not so few cells that many droplets in chamber stay without cells. For this, we 
compared two S49.1 concentrations, 2.5x106 cell/ml (Figure 10 A and B) and 5x106 
cell/ml (Figure 10 C and D), cultivated for 1 day in agarose droplets and marked 
with cell tracker. When cell concentration was 2.5x106 cell/ml, there were almost 
10 cells/droplet after 1 day (Figure 10 A), and when 5x106 cell/ml, there were about 
20 cells/droplet (Figure 10 D). So, we decided to use 2.5x106 cell/ml in the next 
studies to have a reasonable quantity of cells after at least 7 days incubation 
during transfection processes, and to produce less quantity of metabolites that 
could be toxic for cells.  
A B 
  
C D 
  
Figure 10 – Images of lymphoma cells market with cell tracker cultivated in 
agarose hydrogel droplets for 0 and 1 day incubation at 2.5x106 cells/ml (A and B) 
and 5x106 cells/ml (C and D).  
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Then, we transfected 2.5x106 lymphoma cells/ml marked with cell tracker 
inside agarose droplets for 7 (Figure 11 B) and 11 days (Figure 11C). The 
lipoplexes cationic liposomes/pDNA were in a molar charge ratio at (R+/-) at 5 and 
around 1.3x10-4 µg of DNA/droplet. About 10% of cells were transfected after 7 day 
incubation and in 11 days it increased to 20% of transfection. However, after 7 
days of incubation we realized that cells were not typically round as in the 
beginning (Figure 11 A), showing that they maybe were in apoptosis or dead. But, 
seeing movies of changing phases process (from oil to medium) we saw that there 
was still oil around droplets, and these would be the cause to cells death. Because 
of that, we changed trap design from cylindrical to hexagonal form in order to drain 
the oil easier by trap angles. Other transfection experience drawback was the high 
green background showed in fluorescence images, which hinders the detection of 
transfected cells. We verified, by taking fluorescence images from the medium, that 
probably the background showed came from the medium. As a strategy, we 
decided to change the medium for PBS buffer only when taking pictures. 
A B C 
   
 
  
Figure 11 – Images of lymphoma cells (Ccell = 2.5x10
6 cells/ml) stained with cell 
tracker, cultivated in agarose and transfected with lipoplexes (DNA/cationic 
liposomes at a molar charge ratio of R+/-=5) for 0 day (A), 7 days (B) and 11 days 
(C). Detached green fluorescent images of transfected cells in their respectively 
day of incubation. 
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Then, we transfected lymphoma cells again (Ccell=2.5x10
6cell/ml) with 
lipoplexes at R+/- 5 inside agarose droplets kept in hexagonal traps for 1 (Figure 11 
A) and 7 days (Figure 11 B) incubation. In one day incubation, there was almost no 
transfection, but in 7 days, 20% of cells were transfected. So, comparing to the last 
transfection result, we can see that the number of cells transfected in the same 
period of cells incubation, 7 days, increased 10% and also the green background in 
the fluorescence images disappeared, changing medium for PBS buffer when 
taking images.  
Aiming to quantify cell viability in this transfection condition, we marked cells 
with live/dead staining and took images in 1 day (Figure 11 C) and 7 days (Figure 
11 D) of culture. Since cells marked with green are alive and with red are died, 
around 50% of them were dead in the first day and 70% in 7 days. We do not know 
why many of them were died in chip, maybe they were high exposure to live/dead 
probes being toxic for them, or the oil were still not well drained around droplets.   
A B C D 
    
  
  
Figure 12 – Images of lymphoma cells (Ccell = 2.5x10
6 cells/ml) cultivated in 
agarose, transfected with lipoplexes (DNA/cationic liposomes at a molar charge 
ratio of R+/-=5) for 1 day (A) and 7 days (B), or marked with live/dead staining for 1 
day (C) and 7 days (D). Detached green fluorescent images of transfected cells in 
their respectively day of incubation. 
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4. Conclusions 
We develop a microchip which with we were able to transfect adherent 
(SMCs and MSCs) and non-adherent (S49.1) mammalian cells spending little 
quantities of reagents and obtaining many replicates and data in only one 
experiment. High SMCs concentration (4x106 cells/ml) in collagen at 1.2 mg/ml and 
6 mg/ml make cluster structures after 1 day in culture, being difficult to identify 
number of cells transfected. But, decreasing cell concentration to 2.5x106 cells/ml 
in collagen at 6 mg/ml, SMCs stayed spreaded after 1 day, however if we marked 
cells with cell tracker, they did not do the cluster structure, but they do not spread 
as well. SMCs transfected in this condition achieve almost 35% of transfection in 7 
days incubation. Using Rho ROCK inhibitors, like Y27632 and blebbistatin, in soft 
matrices (Ccell = 4x10
6 cells/ml and Ccollagen=1.2 mg/ml) seems to be a good 
strategy to maintain SMCs and MSCs spreaded and without shrinking, and also a 
potential tool to investigate the pathway used by cells for transfection. In the case 
of lymphoma cells, we showed that transfection was better in microchip with 
hexagonal traps to drain better the oil around droplets, reaching about 20% of 
transfection in 7 days incubation, however with cells viability very low.  
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